TW200846472A - Novel a-galactosidase - Google Patents

Novel a-galactosidase Download PDF

Info

Publication number
TW200846472A
TW200846472A TW097105759A TW97105759A TW200846472A TW 200846472 A TW200846472 A TW 200846472A TW 097105759 A TW097105759 A TW 097105759A TW 97105759 A TW97105759 A TW 97105759A TW 200846472 A TW200846472 A TW 200846472A
Authority
TW
Taiwan
Prior art keywords
galactosidase
raffinose
amino acid
strain
enzyme
Prior art date
Application number
TW097105759A
Other languages
Chinese (zh)
Other versions
TWI363093B (en
Inventor
Shinichi Imazu
Kazunobu Konishi
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Publication of TW200846472A publication Critical patent/TW200846472A/en
Application granted granted Critical
Publication of TWI363093B publication Critical patent/TWI363093B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A novel a-galactosidase with which raffinose can be selectively synthesized. The a-galactosidase has the property of attaining a selectivity to raffinose of 65% or higher when the dehydrating condensation of sucrose and galactose as raw materials yields oligosaccharides having a raffinose content of 0.5% or higher.

Description

200846472 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種新穎α-半乳糖酶、及使用該等來製造 棉子糖之方法。 【先前技術】 近年來,伴隨飲食生活及社會生活之多樣化,消費者的 健康意識有所提高,故而對於食品或食品原料等之關注逐 曰上升。其中,棉子糖被認為具有改善腸内細菌群落等功 能,作為飲食品或醫藥品、香粧品等、或其原料而倍受關 /主進而,最近發現棉子糖對於免疫賦活作用或異位性皮 膚炎亦有用。 二刖,棉子糖可作為製造甜菜糖時之副產物而回收,但 甜采中之棉子糖含量僅有〇.1%左右,生產量亦與作為主產 物^砂糖之生產量相關,故而棉子糖之增產存在極限。 口此’ 4 了廉價且穩定地向市場供給具有如此有用之特200846472 IX. Description of the Invention: [Technical Field of the Invention] The present invention relates to a novel α-galactosidase, and a method of producing the raffinose using the same. [Prior Art] In recent years, with the diversification of dietary life and social life, consumers' health awareness has increased, so the concern for food or food ingredients has increased. Among them, raffinose is considered to have functions such as improving bacterial communities in the intestines, and it has been closely taken as a food or beverage, a pharmaceutical, a cosmetic, or the like, and it has recently been found that raffinose has an effect on immunity or ectopic Sexual dermatitis is also useful. Second, raffinose can be recovered as a by-product of the production of beet sugar, but the content of raffinose in sweetness is only about 1%, and the production amount is also related to the production of the main product, sugar. There is a limit to the increase in the production of raffinose. This is a cheap and stable supply to the market.

的棉子糖’不僅需要來自天然物質之萃取物,亦需要來 自廉價之原料的合成品。 作為至今為止所營 半乳糖酶之觸媒;==成方法’可列舉利用 糖作為半乳糖受體 L “有如下方法.使用蔗 得棉子糖的方法(心 糖作為半乳糖供體,而獲 非專利文獻2)1報1有參照專利文獻1、料利文獻卜 芽作為半隸供體之;Μ制㈣基苯·α·Μ喃半乳糖 肌醇半乳糖料為半參照料利文獻〜利用 牛礼糖供體之方法(例如,參照專利文 129208.doc 200846472 獻2)、利用半乳二糖作為半乳糖供體之方法(例如,參照專 利文獻3)等。 又,亦報告有幾種可利用低價之蔗糖及半乳糖作為原料 之例。例如揭示有:使用來自朱紅栓菌(Pycn〇p〇rus einnabarinus)之心半乳糖酶而獲得棉子糖的方法(例如,參 照非專利文獻4)、或利用來自葡酒色被孢黴(—“Μ vinacea)之α-半乳糖酶而合成棉子糖的方法(例如,參照非 專利文獻5)。 [專利文獻1]曰本專利第2688854號 [專利文獻2]日本專利特開平m4973 [專利文獻3]日本專利特公平8_24592 [非專利文獻 1] Agdc. Biol. Chem,,52⑼,23〇5_2311, 1988 ’ [非專利文獻 2] Biosci· Biotech· Bi〇chem, 59(4),619_ 623, 1995 [非專利文獻 3] Phytochemistry,18, 35-38.,1979 [非專利文獻 4] Nippon Shokuhin K〇gy〇 38(8),722-728, 1991 [非專利文獻 5] Carbohydr. Res·,185, 139_146, 1989 【發明内容】 ’ [發明所欲解決之問題] 由於利用α·半乳糖酶之棉子糖生成效率良好,故而報告 有利用蜜二糖、對硝基苯协吡嗔半乳糖苦、肌醇半乳 糖苦或半乳二糖作為棉子糖合成原料之例子,但於使用該 等方法之情形時,所使用之原料價格高,且難以於卫業水 129208.doc 200846472 平製造棉子糖。The raffinose does not only require extracts from natural substances, but also synthetic products from inexpensive raw materials. As a catalyst for galactosidase so far; == method for forming 'may use saccharide as galactose receptor L. "There is the following method. Using cane to obtain raffinose (cardioose as a galactose donor, Obtained non-patent literature 2) 1 reported 1 reference patent document 1, material literature bud as a semi-substitute; tanning (tetra) phenyl benzene · α · galacto-galactose galactose galactose is a semi-reference material a method of using a bovine sugar donor (for example, refer to Patent Document 129208.doc 200846472 2), a method using galactose as a galactose donor (for example, refer to Patent Document 3), etc. There are several examples in which low-cost sucrose and galactose can be used as raw materials. For example, there is disclosed a method of obtaining raffinose using heart galactosidase from Pycn〇p〇rus einnabarinus (for example, reference non- Patent Document 4) or a method of synthesizing raffinose using α-galactosidase derived from Mortierella sinensis (-"Vinacea" (for example, refer to Non-Patent Document 5). [Patent Document 1] Japanese Patent No. 2688854 [Patent Document 2] Japanese Patent Laid-Open Publication No. M4973 [Patent Document 3] Japanese Patent Special Publication No. 8_24592 [Non-Patent Document 1] Agdc. Biol. Chem,, 52(9), 23〇5_2311, 1988 ' [Non-Patent Document 2] Biosci Biotech· Bi〇chem, 59(4), 619_623, 1995 [Non-Patent Document 3] Phytochemistry, 18, 35-38., 1979 [Non-Patent Document 4] Nippon Shokuhin K 〇 〇 〇 38 (8), 722-728, 1991 [Non-Patent Document 5] Carbohydr. Res., 185, 139_146, 1989 [Summary of the Invention] [Problem to be solved by the invention] Due to the use of α-galactosidase The production efficiency of raffinose is good, so the use of melibiose, p-nitrophenyl pyridinium galactose, inositol galactose or galactobiose as an example of raw material for raffinose has been reported, but such use is used. In the case of the method, the raw materials used are expensive, and it is difficult to manufacture raffinose in the water of 129208.doc 200846472.

糖:方、Ϊ面’、使用來自朱紅栓8 .半乳糖酶而獲得棉子 二或利用來自葡酒色被孢黴之α半乳糖酶而合成 =子^的方法’可利用作為廉價原料之蔗糖及半乳糖,因 ^自工業性方面考慮,上料種方法係㈣有利之方 ,。然而’於利用該#α_半乳糖酶之情形時,於產物中會 、成目‘棉子糖以外之夾雜三糖,因此必須自最終產品中 :離爽雜三糖’進而產生浪費原料之問題。於將來自朱红 王囷之乳糖酶心棉子糖合成反應之情形時,生 ==棉子糖含有率為4G%;於將來自葡酒色被孢徵之… 礼糖㈣於棉子糖合纽叙情料,生成寡糖中之棉 :糖含有率為峨,含有率均較低,故切之技術無法藉 由轉法而選擇性製造棉子糖。 土於上述狀況’本發明係提供一種可使用廉價原料,選 擇性合成棉子糖之新賴α_半乳糖酶,且提供—種使用有上 述新穎α-半乳糖酶之創新的棉子糖製造方法。 [解決問題之技術手段] 本I明者等人為解決該等課題而反覆進行潛心研究,沣 果發現一種可選擇性合成棉子糖之新穎酶,且發現一種= 制目標棉子m卜之夾雜募糖之生成的棉子糖製造, 從而完成了本發明。 即,本發明係關於以下[1]〜[20]所示之新穎心半乳糖酶 及棉子糖之製造方法等。 Π] 一種α-半乳糖酶,其具有下述特性: 129208.doc 200846472 (1) 作用:於以蔗糖及半乳糖為原料之脫水縮合反應中,生 成寡糖中之棉子糖含有率為0.5%以上時,α-半乳糖酶具有 棉子糖合成選擇率為65%以上之性質; (2) 最佳pH值範圍:3.5〜5.0 ; (3) 穩定pH值範圍:3.5〜10.0 ; (4) 分子量:約80,000。 [2] 如[1]之α-半乳糖酶,其係來自屬於凝結芽胞桿菌 (Bacillus coagulans)之微生物。 [3] 如[2]之α-半乳糖酶,其中凝結芽胞桿菌係凝結芽胞 桿菌 AKC003 株、AKC004 株(FERM-ABP10948)(台灣寄存 編號:BCRC 910388)、AKC005 株、AKC006株中之任一 者。 [4] 一種凝結芽胞桿菌及其變異體,該凝結芽胞桿菌屬 於凝結芽胞桿菌AKC003株 、AKC004株(FERM-ABP 10948)(台灣寄存編號:BCRC 910388)、AKC005株、 AKC006株中之任一者。 [5] —種α-半乳糖酶,其包含下述(a)、(b)或(c)中之任一 個胺基酸序列: (a) 序列編號2所表示之胺基酸序列; (b) 序列編號2所表示之胺基酸序列中,一個或數個胺基酸 經缺失、置換及/或附加,且具有α-半乳糖酶活性之胺基酸 序列; (c) 與序列編號2所表示之胺基酸序列具有60%以上之同源 性,且具有α-半乳糖酶活性的胺基酸序列。 129208.doc 200846472 [6] —種α -半季丨 牛礼糖_基因’其對包含下述⑷、(b 之任一個胺基酸成 •序列之α-半乳糖酶進行編碼: (a)序列編號2辦主_ _ 以所表不之胺基酸序列; (b)序列編號2所在- 所表不之胺基酸序列中,一個或數個胺基酸 經缺失、置拖B + & 、 或附加,且具有心半乳糖酶活性之胺基酸 序列; ()’、序列編唬2所表示之胺基酸序列具有6〇%以上之同源Sugar: square, noodles', using the method of obtaining cottonseed from the galactose 8. galactosidase or using the α-galactosidase from the genus Mortierella sinensis to synthesize = sub-^ can be used as an inexpensive raw material for sucrose And galactose, because of the industrial considerations, the method of feeding is the (four) favorable side. However, in the case of using the #α_galactosidase, it is possible to form a trisaccharide in addition to the raffinose in the product, and therefore must be from the final product: from the dry trisaccharide, which in turn produces wasteful raw materials. problem. In the case of synthesizing the lactose heart raffinose from the red ginseng, the raw == raffinose content is 4G%; in the case of the succulent succulent sucrose from the succulent succulent succulent The cotton in the oligosaccharide is produced: the sugar content is 峨, and the content rate is low, so the cutting technique cannot selectively produce raffinose by the transfer method. In the above circumstances, the present invention provides a novel lysine α-galactosidase which can selectively synthesize raffinose using an inexpensive raw material, and provides an innovative cotton saccharide production using the novel α-galactosidase described above. method. [Technical means to solve the problem] The present inventors have repeatedly studied the problem to solve these problems, and found a novel enzyme that can selectively synthesize raffinose, and found a kind of inclusion of the target cotton. The production of raffinose which is produced by sugar collection has completed the present invention. In other words, the present invention relates to a novel cardiac galactosidase and a method for producing raffinose, which are shown in the following [1] to [20]. α] An α-galactosidase having the following characteristics: 129208.doc 200846472 (1) Action: In the dehydration condensation reaction using sucrose and galactose as raw materials, the content of raffinose in the oligosaccharide is 0.5. Above %, α-galactosidase has a carnosamine synthesis selectivity of 65% or more; (2) Optimal pH range: 3.5 to 5.0; (3) Stable pH range: 3.5 to 10.0; (4) ) Molecular weight: about 80,000. [2] The α-galactosidase of [1], which is derived from a microorganism belonging to Bacillus coagulans. [3] α-galactosidase such as [2], which is any one of Bacillus coagulans bacillus AKC003 strain, AKC004 strain (FERM-ABP10948) (Taiwan registration number: BCRC 910388), AKC005 strain, AKC006 strain. By. [4] A Bacillus coagulans and a variant thereof, the Bacillus coagulans belonging to any one of Bacillus coagulans AKC003 strain, AKC004 strain (FERM-ABP 10948) (Taiwan registration number: BCRC 910388), AKC005 strain, and AKC006 strain . [5] an α-galactosidase comprising the amino acid sequence of any one of the following (a), (b) or (c): (a) an amino acid sequence represented by SEQ ID NO: 2; b) an amino acid sequence having one or several amino acids deleted, substituted and/or added, and having α-galactosidase activity in the amino acid sequence represented by SEQ ID NO: 2; (c) and sequence number The amino acid sequence represented by 2 has an amino acid sequence having a homology of 60% or more and having α-galactosidase activity. 129208.doc 200846472 [6] A kind of α-semi-season yoghurt _gene' encodes α-galactosidase containing any of the following amino acids (b): (b) SEQ ID NO: 2 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ; or an additional amino acid sequence having cardiac galactosidase activity; ()', the amino acid sequence represented by sequence 2 has more than 6% homology

性’且具有α _丰聋 千礼糖it活性之胺基酸序列。 []種^半礼糖酶基因,其包含以下⑷或(b)之驗基序 列: ⑷序列編號1所表示之鹼基序列; ⑻序H虎1所表示之驗基序列中,—個或數個驗基經缺 失、置換及/或附加,且編碼具有心半乳糖酶活性之蛋白質 之驗基序列。 []種重組栽體,其含有如[6]或[7]之α-半乳糖酶基 因。 [9] 種轉形體,其導入有如[6]或[7]之α-半乳糖酶基因 或如[8]之重組載體。 [10] 種α半乳糖酶,其係培養如[9]之轉形體而獲得。 [11] 一種酶組合物,其含有如Π]至[3]、[5]、或[1〇]中任 一項之α-半乳糖酶。 [12] 如[11]之酶組合物,其進而含有選自心葡萄糖苷 酶、卜葡萄糖苷酶、β-半乳糖酶、纖維素酶、木聚糖酶、 蛋白酶、半乳聚糖酶、阿拉伯聚糖酶、甘露聚糠酶、鼠李 129208.doc -10- 200846472 . _乳糖駿酸酶、聚半乳糖Μ酶、果膠甲㈣、果膠解離 酶、及聚半乳糖醛酸解離酶中之至少一種以上之成分。 [13]—種棉子糖合成試劑,其含有如中任一項 之酶組合物。 ' • Π4]種棉子糖之製造方法,其特徵在於:其係使用如 [1]至[3]、[5]、或[1〇]中任一項之半乳糖酶,如⑴]或 [12]之酶組合物,或者如[13]之棉子糖合成試劑。 • [15]一種棉子糖之製造方法,其特徵在於:其係利用培 養屬於凝結芽胞桿菌之微生物而獲得之微生物觸媒。 [1 6] —種棉子糖之製造方法,其特徵在於:其係利用培 養屬於凝結芽胞桿菌AKC〇〇3株、AKC〇〇4株(ferm_ ABP1〇948)(台灣寄存編號:bcrc 9i義)、AC嶋株、 AKC006株中之任一者的凝結芽胞桿菌及/或其變異體而獲 得的微生物觸媒。 Π7] -種棉子糖之製造方法,其特徵在於:其係利用培 • 養如[9]之轉形體而獲得之微生物觸媒。 _如[14]至[17]中任一項之棉子糖之製造方法,其中生 成寡糖中之棉子糖含有率為65%以上。 [—19]如[14]至[18]巾任—項之棉子糖之製造方法,其係使 • 用蔗糖及半乳糖作為原料。 [〇]如[19]之棉子糖之製造方法,其中原料中之蔬糖濃 度為3〇% (w/v)〜90% (w/v),原料中之半乳糖濃度為2% (w/v)〜45% (w/v)。 [發明之效果] 129208.doc -11 - 200846472 藉由使用本發明,可選擇性製造棉子糖。 【實施方式】 以下,對本發明進行具體說明。 本發明之α-半乳糖酶係來自屬於凝結芽胞桿菌之微生 物,作為該微生物,若為屬於凝結芽胞桿菌之微生物,則 可使用任意者,可使用表現出可選擇性合成棉子糖之α-半 乳糖酶之任意微生物。可較好地列舉:凝結芽胞桿菌 AKC-003 株、AKC‘004 株、AKC-005 株、AKC-006 株。 又,本發明之微生物,亦可為以屬於凝結芽胞桿菌之微生 物為母株而獲得之變異株。凝結芽胞桿菌AKC-003株、 AKC-004株、AKC-005株、AKC-006株分別於 2006年(平成 18年)11月14日,寄存於獨立行政法人產業技術綜合研究 所專利生物寄存中心(日本茨城縣築波市東1 丁目1番地1 中央第6)。寄存編號如下所述。再者,AKC-004株於2008 年(平成20年)1月30曰以受領編號FERM-ABP10948、及寄 存編號FERM-BP10948交由國際寄存管理(台灣寄存編號: BCRC 910388)。 AKC-003株(FERM P-21091) AKC-004株(FERM P-21092 ; FERM-ABP10948 ; FERM-BP 10948)(台灣寄存編號·· BCRC 910388) AKC-005株(FERM P-21093) AKC-006株(FERM P-21094) 本發明之α-半乳糖酶具有下述特性。 (1)作用:於以蔗糖與半乳糖為原料之脫水縮合反應中,生 129208.doc -12- 200846472 成寡糖中之棉子糖含有率為〇 5%以上時,本發明之 糖酶具有棉子糖合成選擇率為65%以上的性質。 (2) 最佳PH值範圍:3.5〜5〇 、 (3) 穩定PH值範圍:3.5〜1〇.〇 (4) 分子量:約8〇,〇〇〇 對於本發明之酶的具體例, 今屬雜工〇 了列舉.作為受質特異性及 五屬離子之影響方面而具有以下性質者。 所受精料苯·α^料乳糖料為受 貝之f月形時,分解活性最高,其次 ",、、、 檣。叉 + 疋虫一糖,再次是棉子 糖不會分解。 …糖皆、乳糖、蔗 金屬離子之影響:於分別添加鉀、舞、鎂、鉻、猛、 2、鐵⑼、鐵⑽離子之情形時,未發現活性下降、。另 降方:八於分別添加鎳、鋅離子之情形時,可見活性下 降,於添加銅離子之情形時活性下降最多。 下 進而’作為本發明之酶之具 者。 j苟具有下述特性 (5) (正反應)最佳溫度範圍·· 35〜5〇它 (6) 穩定溫度範圍:直至判艺為穩定。 作為用於本發明之微生物之谇 氣授摔培養或固體培養,可適用°通=:可使用通常之通 /z_ 用通吊進仃之微生物i立表士 乍為培養基,可列舉··該微生物良好生長,且: 生物申之&半乳糖酶可順利生產所必需之碳源、氮;; 機鹽,必需之營養源等的合成培養基或者丄 129208.doc -13- 200846472 如’作為碳源,可使用:葡萄糖、甘油、蔗糖、半乳糖、 乳糖、蜜二糖、棉子糖、水蘇糖、纖維雙糖、、 機酸、澱粉、橄欖油、大豆油等。作為氣源,例:可列 舉:硫酸錢、硝酸銨、尿素、胺基酸、胺類、氨 機酸或有機酸之铵鹽、其他含氛化合物、蛋白腺 ^ 腺、聚蛋白腺、肉汁、酵母萃取物、棉籽粕、玉米漿、及 旦餅等。X’作為無機鹽類,可使用:碟酸二氣卸、碟酸 氫二卸、碌酸鎖、硫酸鎂、氯化納、硫酸猛、硫酸鋼、硫 酸鐵、礙_等。就微生物之生長性方面而言,执養 較好的是25〜,C,更好的是40〜65。〇,更好的1 40〜S5C。又,培養基之pH值可於較大之範圍内 微生物之生長性方面而言,pH值較好的是3 〇〜9 〇,更好 的是PH值為3·5〜8.5,更好的是pH值為4〇〜8〇。 本發明之α-半乳糖酶之分離/精製例如可藉由如下方式實 施0 、 於上述培養基中培養凝結芽胞桿菌AKC-004株,藉由離 心分離、過濾等眾所周知之方法’將所得培養液分離為菌 體與濾液。 困 如此獲得之菌體中含有…半乳糖酶,可使用溶菌酶或超 音波粉碎機、法式高廢破碎機等對菌體進行粉碎,藉此# 得《_半乳糖酶之粗萃取液。因培養條件等而使培養上清^ 含有(X-半乳糖酶之活性之情形時,亦可直接將培養上清 液、,將經過遭縮等操作後之培養上清液作為心半乳糖酶 之粗萃取液而用於之後的精製中。 129208.doc -14 - 200846472 可組合通常之蛋白之精製法,例如離子交換 * 水層析法、凝膠過濾層析法:’、疏 專對以上述方式㈣得之粗萃取液進行 心半乳糖酶。 猎此精製 上述操作之順序並無特別限 以F。V > 合辉作可進行1次或2次 析等使^父理想的是,於將樣品通入各管柱前,藉由透 專使樣液與適當之緩衝液進行交換 段濃縮樣品液。 』於各階 所1 交理想的是1精製之各階段,測定所分離之各組分中 3之0C-半礼糖酶活性’收集活性較高之組 個階段試驗。 供、·、。至下 作為敎α·半乳糖酶活性之方法,例如有如下方法於 含有6mM之對硝基苯·㈣♦南半乳糖普之阳值為_ 100 mM醋酸鈉緩衝液45〇 #中,混合酶液15〇叫,於贼 下使其反應5〜30分鐘左右後,將其添加至i m之碳酸納水 溶液1紅中,使酶失活,而停止反應。對所得溶液之著色 度測定於波長420 nm處之吸收峰,使用以各濃度之對石肖基 苯紛製作之校正曲線算出濃度。又,酶活性之單位係將上 述條件下於1分鐘内使i μ m 〇 i之對確基苯齡游離的酶量表 示為1 U。 確認經精製之a-半乳糖酶之精製度及測定分子量,可藉 由電泳或凝膠過濾層析法等而進行。又,酶學性質可藉由 如下方法進行研究:改變反應溫度或反應_值,而測定酶 活性,或者於反應液中添加各種酶抑制劑或金屬離子等, 129208.doc -15- 200846472 再測定殘留活性。 溫度條件下暴露-定時門糖酶於各灣條件下或 定阳值範圍及穩定溫度;圍::疋酶:性,藉此可研究穩 行反應,可七山 错由改變受質濃度而進 ⑹、最大速度(Vm士㈣相對於各受質之米氏常數 行本毛明之心半乳糖酶基因之獲取例如可藉由以下方式進 、:上述培養基中培養凝結芽胞桿菌AKC__株,藉由離 、過料眾·知之方法將所得培養液分離為菌體 Π/使㈣^酶或超音波粉碎機、法式高Μ破碎機 以上述方式獲得之菌體進行粉碎,使染色體職離 析。二各種制限酶,消化以上述方式獲得之染色體職, :獲侍DNA片段。使用以上述方式獲得之染色體爾片 段,藉由利用散彈搶選殖法或反向pcR法等之眾所周知的 方法’獲取包含半乳糖酶基因之全長或其一部分之職 片,。藉由利用魏測序儀等之眾所周知的方法,對此處 所得之包含《_半乳糖酶基因之舰片段之驗基序列進行分 析’而明確其驗基序列。又’於僅明確心半乳糖酶基因之 部分驗基序列之情形時,亦可以該驗基序列為基礎,再次 獲取包含α-半乳糖酶基因之DNA片段。χ,藉由反覆進行 該操作’亦可明確α·半乳糖酶基因全長之鹼基序列。將以 上述方式方式解碼之α_半乳糖酶基因之鹼基序列作為基 礎,藉由使用PCR法或制限酶之眾所周知的方法,可獲得 包含α-半乳糖酶基因全長之DNA片段。自以上述方式^碼 129208.doc -16 - 200846472 之α-半乳糖酶基因的驗基序列,可決定α_半乳糖酶之胺基 酸序列。 於序列編號2中例示有本發明之α_半乳糖酶之胺基酸序 列,但只要包含該胺基酸序列之蛋白質具有α_半乳糖酶活 性,則於该胺基酸序列中亦可產生至少一個胺基酸缺失、 置換、附加等之變異,或者可為與該胺基酸序列具有6〇% 以上之同源性的胺基酸序列。即,本發明之α-半乳糖酶, 係包含下述(a)、(b)或(c)中之任一個胺基酸序列的心半乳 糖酶。 (a)序列編號2所表示之胺基酸序列; ()於序歹】、、扁號2所表示之胺基酸序列中,一個或數個胺基 酉欠經缺失、置換及/或附加,且具有心半乳糖酶活性的胺基 酸序列; (C)與序列編號2所表示之胺基酸序列具有60%以上之同源 1*生且具有心半乳糖酶活性的胺基酸序列。 進而,本發明提供一種α_半乳糖酶基因,其係對包含下 述(a)、(b)或(c)中之任一個胺基酸序列之α_半乳糖酶進行 編碼: (a) 序列編]虎2所表示之胺基酸序列; (b) 於序列編號2所表示之胺基酸序列中,一個或數個胺基 酉曼、經吹 \ 甲 置換及/或附加,且具有α-半乳糖酶活性的脸其 酸序列; 妝丞 (e)與序列編f虎2所表示之胺&酸序列具有6〇%以上之同源 性,且里古 、上 ’、 /、3 α_半乳糖酶活性的胺基酸序列。 129208.doc -17- 200846472 上述(b)中之「一個或數個胺基酸」,通常係指丨〜兄個胺 基酸,較好的是卜儿個胺基酸,更好的是卜⑽個胺基酸, 更好的是1〜10個胺基酸,尤其好的是1〜5個胺基酸。 ^述(e)中之「具有60%以上之同源性之胺基酸序列」, 通术係私具有6〇%以上,較好的是以上,更好的是 8〇%以上’更好的是90%以上,更好的是95%以上,尤其 好的是99%以上之同源性的胺基酸序列。And has the amino acid sequence of α _ 聋 千 千 it it activity. [] a semi-glycosidase gene comprising the following sequence of (4) or (b): (4) the base sequence represented by SEQ ID NO: 1; (8) in the sequence of the sequence represented by H H1, - or A number of assays are deleted, substituted and/or affixed and encode a sequence of a protein having cardiac galactosidase activity. [] A recombinant vector containing an α-galactosidase gene such as [6] or [7]. [9] A transformant into which an α-galactosidase gene of [6] or [7] or a recombinant vector such as [8] is introduced. [10] An α-galactosidase obtained by culturing a transformant such as [9]. [11] An enzyme composition comprising an α-galactosidase according to any one of [3], [5], or [1〇]. [12] The enzyme composition according to [11], which further comprises a selected from the group consisting of cardiac glucosidase, glucosidase, β-galactosidase, cellulase, xylanase, protease, galactanase, Arabinanase, mannose polyzyme, buckthorn 129208.doc -10- 200846472 . _ lactose enzyme, polygalactosidase, pectin A (tetra), pectin dissociation enzyme, and polygalacturonolytic enzyme At least one or more of the ingredients. [13] A raffinose synthesizing agent comprising the enzyme composition according to any one of the above. a method for producing a raffinose, which is characterized in that it uses a galactosase such as any one of [1] to [3], [5], or [1〇], such as (1)] or [12] The enzyme composition, or the raffinose synthesis reagent according to [13]. [15] A method for producing raffinose, which is characterized in that it is a microbial catalyst obtained by cultivating a microorganism belonging to Bacillus coagulans. [1 6] A method for producing a raffinose, characterized in that it is cultured to belong to Bacillus coagulans AKC〇〇3 strain, AKC〇〇4 strain (ferm_ABP1〇948) (Taiwan registered number: bcrc 9i A microbial catalyst obtained by Bacillus coagulans and/or a variant thereof of any of the AC strain and the AKC006 strain. Π7] A method for producing a raffinose, which is characterized in that it is a microbial catalyst obtained by cultivating a transformant such as [9]. The method for producing raffinose according to any one of [14] to [17] wherein the raffinose content in the oligosaccharide is 65% or more. [-19] The method for producing raffinose according to [14] to [18] towel, which uses sucrose and galactose as raw materials. [〇] The method for producing raffinose according to [19], wherein the concentration of the vegetable sugar in the raw material is 3〇% (w/v) to 90% (w/v), and the concentration of galactose in the raw material is 2% ( w/v) ~45% (w/v). [Effects of the Invention] 129208.doc -11 - 200846472 By using the present invention, raffinose can be selectively produced. [Embodiment] Hereinafter, the present invention will be specifically described. The α-galactosidase of the present invention is derived from a microorganism belonging to Bacillus coagulans, and as the microorganism, if it is a microorganism belonging to Bacillus coagulans, any one may be used, and α-which exhibits selective synthesis of raffinose may be used. Any microorganism of the galactosidase. Preferably, Bacillus coagulans AKC-003 strain, AKC '004 strain, AKC-005 strain, and AKC-006 strain are listed. Further, the microorganism of the present invention may be a mutant obtained by using a microorganism belonging to Bacillus coagulans as a mother strain. Bacillus coagulans AKC-003, AKC-004, AKC-005, and AKC-006 were deposited in the Patent Bioburden Center of the Institute of Industrial Technology, the Independent Administrative Corporation, on November 14, 2006 (Heisei 18). (1st, the central part of the 1st, 1st, 1st, 1st, 1st, 1st, 1st, 1st, 1st, 1st, The registration number is as follows. Furthermore, the AKC-004 strain was handed over to the International Depository Management (Taiwan Registration Number: BCRC 910388) on January 30, 2008 (2008) with the recipient number FERM-ABP10948 and the deposit number FERM-BP10948. AKC-003 strain (FERM P-21091) AKC-004 strain (FERM P-21092; FERM-ABP10948; FERM-BP 10948) (Taiwan registration number · BCRC 910388) AKC-005 strain (FERM P-21093) AKC- 006 strain (FERM P-21094) The α-galactosidase of the present invention has the following characteristics. (1) Action: In the dehydration condensation reaction using sucrose and galactose as raw materials, when the content of raffinose in the oligosaccharide is 〇 5% or more, the carbohydrase of the present invention has The raffinose synthesis selectivity is 65% or more. (2) Optimum pH range: 3.5~5〇, (3) Stable pH range: 3.5~1〇.〇(4) Molecular weight: about 8〇, 〇〇〇 For the specific example of the enzyme of the present invention, It is classified as a handyman. It has the following properties as a result of the influence of the substance-specificity and the five-genus ion. When the benzene-α-containing lactose material is subjected to the f-shaped shape of the shell, the decomposition activity is the highest, followed by ",,,, and 樯. Fork + mites and sugar, once again, the cotton nectar will not break down. ... Sugar, lactose, sugar cane Metal ion effect: When potassium, dance, magnesium, chromium, fierce, 2, iron (9), iron (10) ions were added, no decrease in activity was observed. Another drop: When the nickel and zinc ions were added separately, the activity decreased, and the activity decreased most when copper ions were added. Further, as the enzyme of the present invention. J苟 has the following characteristics: (5) (positive reaction) optimum temperature range ·· 35~5〇 It (6) Stable temperature range: until the judgment is stable. As a helium gas culture or solid culture for use in the microorganism of the present invention, it is applicable to the use of a normal medium, which can be used as a medium, and the microorganism can be used as a medium. The microorganisms grow well, and: the biological medium and the galactosidase can produce the carbon source and nitrogen necessary for the smooth production; the synthetic medium of the organic salt, the essential nutrient source, etc. or 丄129208.doc -13- 200846472 For the source, glucose, glycerin, sucrose, galactose, lactose, melibiose, raffinose, stachyose, cellobiose, organic acid, starch, olive oil, soybean oil and the like can be used. As the gas source, for example, sulfuric acid, ammonium nitrate, urea, amino acid, amine, ammonium or organic acid ammonium salt, other occluding compounds, protein glands, polyprotein glands, gravy, Yeast extract, cottonseed meal, corn syrup, and cakes. As the inorganic salt, X' can be used: two-disc discharge of a dish, a hydrogen-discharge of a dish, a sulphuric acid lock, a magnesium sulfate, a sodium chloride, a sulfuric acid, a steel sulfate, an iron sulfate, and the like. In terms of the growth of microorganisms, it is preferred to carry out 25~, C, and more preferably 40~65. Hey, better 1 40~S5C. Further, the pH of the medium may be in the range of growth of microorganisms in a larger range, and the pH is preferably 3 〇 to 9 〇, more preferably 3 to 5 8.5, more preferably The pH is 4〇~8〇. The separation/purification of the α-galactosidase of the present invention can be carried out, for example, by culturing the Bacillus coagulans AKC-004 strain in the above medium, and separating the obtained culture solution by a known method such as centrifugation, filtration, or the like. For the bacteria and filtrate. The cells thus obtained contain ... galactosidase, and the cells can be pulverized using a lysozyme, an ultrasonic pulverizer, a French high-waste crusher, etc., thereby obtaining a crude extract of _galactosidase. When the culture supernatant is contained (for the activity of X-galactosidase), the culture supernatant may be directly used, and the culture supernatant after the operation such as contraction may be used as the cardiac galactosidase. The crude extract is used in the subsequent purification. 129208.doc -14 - 200846472 It is possible to combine the purification methods of common proteins, such as ion exchange* water chromatography, gel filtration chromatography: ', sparse The crude extract obtained in the above manner (4) is subjected to cardiac galactosidase. The order of the above operations is not limited to F. V > Hehui can be performed once or twice, so that the father is ideal, Before the sample is passed into each column, the sample liquid is concentrated by exchanging the sample solution with an appropriate buffer. The ideal part of each stage is the stage of 1 refining, and the separated components are determined. The 3C-half-glucosidase activity of the middle 3 is a group stage test with a higher collection activity. The method of supplying the 敎α·galactosidase activity, for example, has the following method for the nitro group containing 6 mM. Benzene (4) ♦ Southern galactose yin value _ 100 mM sodium acetate buffer In 45〇#, the mixed enzyme solution 15 is called, and after reacting for 5 to 30 minutes under the thief, it is added to the aqueous solution of im sodium carbonate 1 red to inactivate the enzyme, and the reaction is stopped. The chromaticity was measured at an absorption peak at a wavelength of 420 nm, and the concentration was calculated using a calibration curve prepared for each concentration of the osmotic benzene. Further, the unit of the enzyme activity was i μ m 〇i within 1 minute under the above conditions. The amount of the enzyme which is free of the phenyl group is expressed as 1 U. It is confirmed that the purified a-galactosidase system and the molecular weight are determined by electrophoresis or gel filtration chromatography. The nature can be studied by changing the reaction temperature or the reaction_value to measure the enzyme activity, or adding various enzyme inhibitors or metal ions to the reaction solution, and measuring the residual activity by 129208.doc -15-200846472. Under the conditions of exposure-timed-gate carbohydrase under the conditions of each bay or the range of steadiness and stable temperature; circumference:: chymase: sex, which can be used to study the steady response, Qishan error by changing the concentration of the drug (6) Maximum speed (Vm Shi (four) phase For example, the Bacillus coagulans AKC__ strain can be cultured in the above medium by the Michaelis constant of each of the M. sinensis constants, and the obtained Bacillus coagulans AKC__ strain can be obtained by the method of separation The culture medium is separated into a bacterial cell/[4], an enzyme, an ultrasonic pulverizer, and a French sorghum crusher, which are pulverized in the above manner to cause chromosomal segregation. Two kinds of enzymes are limited, and the chromosome obtained by the above method is digested. Job, : Obtaining a DNA fragment. Using the chromosomal fragment obtained in the above manner, the full length or part of the galactosidase-containing gene is obtained by using a well-known method such as a shotgun or a reverse pcR method. Job film,. The nucleotide sequence of the fragment of the ship fragment containing the "galactosidase gene" obtained here is determined by a well-known method such as a Weser Sequencer. Further, in the case where only a part of the nucleotide sequence of the cardiac galactosidase gene is specified, the DNA fragment containing the α-galactosidase gene can be obtained again based on the sequence of the test. In other words, by repeating this operation, the base sequence of the entire length of the α-galactosidase gene can be confirmed. Based on the base sequence of the α-galactosidase gene decoded in the above manner, a DNA fragment containing the full length of the α-galactosidase gene can be obtained by a well-known method using a PCR method or a restriction enzyme. The amino acid sequence of the α-galactosidase can be determined by the sequence of the α-galactosidase gene of the above method 129208.doc -16 - 200846472. The amino acid sequence of the α-galactosidase of the present invention is exemplified in SEQ ID NO: 2, but may be produced in the amino acid sequence as long as the protein comprising the amino acid sequence has α-galactosidase activity. The at least one amino acid is deleted, substituted, affixed or the like, or may be an amino acid sequence having 6% or more homology to the amino acid sequence. Namely, the α-galactosidase of the present invention is a cardiac galactase comprising the amino acid sequence of any one of the following (a), (b) or (c). (a) an amino acid sequence represented by SEQ ID NO: 2; () in the amino acid sequence represented by SEQ ID NO: 2, one or several amino hydrazines, which are missing, substituted and/or attached And an amino acid sequence having cardiac galactosidase activity; (C) an amino acid sequence having 60% or more homologous 1* and having cardiac galactosidase activity with the amino acid sequence represented by SEQ ID NO: 2 . Further, the present invention provides an α-galactosidase gene encoding an α-galactosidase comprising any one of the following amino acid sequences (a), (b) or (c): (a) The sequence is the amino acid sequence represented by Tiger 2; (b) one or more of the amino acid thione, blown, and/or attached in the amino acid sequence represented by SEQ ID NO: 2, and has The acid sequence of the α-galactosidase activity of the face; the makeup (e) and the amine & acid sequence represented by the sequence of the tiger 2 have more than 6 % homology, and the ancient, upper ', /, 3 Amino acid sequence of α_galactosidase activity. 129208.doc -17- 200846472 In the above (b), "one or several amino acids" usually means 丨~ brother amino acid, preferably a carboxylic acid, more preferably (10) an amino acid, more preferably 1 to 10 amino acids, particularly preferably 1 to 5 amino acids. The "amino acid sequence with more than 60% homology" in (e) is more than 6〇%, preferably more than above, more preferably more than 8〇%. More than 90%, more preferably more than 95%, especially preferably more than 99% homologous amino acid sequence.

作為本發明之心半乳糖酶基因之具體例,可列舉具有以 下(a)或(b)之鹼基序列之心半乳糖酶基因。 (a)序列編號〗所表示之鹼基序列; ⑻序列編號丨所表示之驗基序列中,—個或數個驗基經缺 換及/或附加,且具有α_半乳糖酶活性之編碼蛋白質 的驗基序列。 上述(b)中之「一個或數個鹼基」,通常係指卜15〇個鹼 ,’較好的是1〜90個驗基,更好的是卜⑼個驗基,更好的 是1〜3〇個驗基,更好的是1〜20個驗基,更好的是卜15個驗 基,更好的是1〜10個驗基,尤其好的是卜5個鹼基。 本發明之α-半乳糖酶基因’可藉由眾所周知之基因操作 方法,於無損纟來之催化反應之性質的情況下實現胜肽之 變異,如此之變異體基因,係指藉由基因工程方法,由本 毛明之α-半乳糖酶基因所製作之人工變異基因,該人工變 異:因可藉由使用定點變異法、或將目標基因之特定二 片段置換為人卫變異DNA等之各種基因工程方法而獲得。 即,作為使α-半乳糖酶中之胺基酸產生缺失、置換 '附加 129208.doc -18- 200846472 等變異之方法,$彳彳 、 、 ^PCR法、易錯PCR法、DNA會雜 法、或製造嵌合酶之方法等眾所周知之方法。 可將以上述方式獲得之完整地 G 3 半礼糖酶之結構某 因之臟片段,插入、連接在 冓基 · 什囷用表現载體,例如 pBluescriptII KS(+)之多選殖位 丄 向構建新的曹纽皙 .=該質體載體中導人有可高效地表現大腸桿菌内作為外 來基因而連接之基因的翻 Μ , 動子,稭由培養將重組質體導 •入大腸桿菌而獲得之轉形體,可表現出大量CX-半乳糖酶。 上述之外’亦可利用各種宿主微生物、载體而表現 大ϊ α-半乳糖酶,<列如藉由培養銚子短芽孢桿菌 (BreV1bacillus ehoshinensis)之轉形體可表現出大量“半 乳糖酶。更詳細而言,作為組入本發明之…半乳糖酶基因 之載體,較好的是可於宿主微生物體内自主增殖之噬菌體 或由質體構建之用於基因重組者,作為嗤菌體載體,例如 於將屬於大腸桿菌之微生物作為宿主微生物之情形時,可 • 使用Xgt · λ(:、Xgt · λΒ等。又,作為質體載體,例如將大 腸桿菌作為宿主微生物之情形時,可使用質體pET_3a、 pET-lla、pET-32a 等 pET 載體(Novagen),或 pgR322、 pBR325、PACYC184、PUC12、pUC13、PUC18、PUC19、 f pUC118、PIN I、Bluescript KS+ ;於將枯草桿菌作為宿主 之情形時,可使用 PWH1520、pUBllO、PKH300PLK ;於 將放線菌作為宿主之情形時,可使用pIj680、pIJ7〇2 ;於 將酵母尤其是啤酒酵母作為宿主之情形時,可使用 YRp7、pYCl、YEpl3等。利用生成有與藉由用於切斷本 129208.doc -19- 200846472 發明之α-半乳糠酶基因之制限酶所生成之DNA末端相同的 制限酶,切斷上述載體而製作載體片段,藉由DNA連接 酶,依據常法使本發明之α-半乳糖酶基因片段與載體片段 結合,藉此可將編碼本發明之α-半乳糖酶基因2DNA組入 目標載體中。Specific examples of the cardiac galactosidase gene of the present invention include a cardiac galactosidase gene having the base sequence of (a) or (b) below. (a) the base sequence represented by the sequence number; (8) the sequence number 丨 indicates the code base sequence, one or several test groups are replaced and/or added, and the code has α_galactosidase activity The base sequence of the protein. The "one or several bases" in the above (b) usually means 15 bases, 'preferably 1 to 90 bases, and more preferably (9) bases, and more preferably 1 to 3 验 one test base, more preferably 1 to 20 test bases, more preferably 15 test bases, and more preferably 1 to 10 test bases, especially 5 bases. The α-galactosidase gene of the present invention can realize the variation of the peptide by a well-known genetic manipulation method without damaging the nature of the catalytic reaction, such a variant gene refers to a genetic engineering method. An artificially mutated gene produced by the alpha-galactosidase gene of Benjamin, which is a genetic engineering method by using a site-directed variation method or a specific two-fragment of a target gene as a human mutated DNA. And get. That is, as a method of deleting the amino acid in the α-galactosidase and replacing the 'additional 129208.doc -18-200846472, etc., $彳彳, , ^PCR method, error-prone PCR method, DNA miscellaneous method, A well-known method such as a method of producing a chimeric enzyme. The visceral fragment of the structure of the complete G 3 galactase obtained in the above manner can be inserted and ligated into a thiol-based expression vector, for example, the polymorphism of pBluescriptII KS(+) Constructing a new Cao Nguyen. = The plastid vector has a gene that efficiently expresses the genes linked to it as a foreign gene in E. coli, and the stalk is cultured to introduce the recombinant plastid into Escherichia coli. The obtained transformant can exhibit a large amount of CX-galactosidase. In addition to the above, 'a large amount of α-galactosidase can be expressed by various host microorganisms and vectors, and the column can be expressed as a large amount of "galactosidase" by culturing a transformant of BreV1bacillus ehoshinensis. More specifically, as a vector incorporating the galactosidase gene of the present invention, a phage which can be independently proliferated in a host microorganism or a plastid for gene recombination is preferred as a bacterium carrier. For example, when a microorganism belonging to Escherichia coli is used as a host microorganism, Xgt · λ (:, Xgt · λΒ, etc. can be used. Further, when a plastid vector, for example, Escherichia coli is used as a host microorganism, it can be used. PET vector (Novagen) such as plastids pET_3a, pET-lla, pET-32a, or pgR322, pBR325, PACYC184, PUC12, pUC13, PUC18, PUC19, f pUC118, PIN I, Bluescript KS+; in the case of Bacillus subtilis as a host PWH1520, pUBllO, PKH300PLK can be used; pIj680, pIJ7〇2 can be used when actinomycetes are used as hosts; yeast, especially brewer's yeast, can be used. In the case of a host, YRp7, pYCl, YEpl3, etc. may be used, and the DNA ends generated by the restriction enzyme produced by the α-galactosidase gene for the purpose of cutting the invention of 129208.doc -19-200846472 are used. The restriction enzyme, the vector is cleaved to prepare a vector fragment, and the α-galactosidase gene fragment of the present invention is bound to the vector fragment by a DNA ligase according to a conventional method, whereby the α-galactose encoding the present invention can be encoded. The enzyme gene 2 DNA is incorporated into the target vector.

作為植入質體之宿主微生物,若重組DnA可穩定且自主 增殖即可,例如於宿主微生物為屬於大腸桿菌之微生物之 情形時,可利用大腸桿菌BL21、大腸桿菌bL21(DE3)、大 腸桿菌BL21trxB、大腸桿菌Rosetta(DE3)、大腸桿菌 Rosetta、大腸桿菌 R〇setta(DE3)pLysS、大腸桿菌 R〇Setta(DE3)PLaCl、大腸桿菌 R〇settaBlue、大腸桿菌 R〇setta_gann、大腸桿菌〇rigami、大腸桿菌〇rig施i、大腸 桿菌Timer、大腸桿菌Dm、大腸桿菌jmi〇9、大腸桿菌 W3110、大腸桿菌C6〇〇等。又,於微生物宿主為屬於桿菌 屬之微,物之情形時,可使用枯草桿菌、巨大芽孢桿菌 等二於微生物宿主為屬於放線菌之微生物之情形時,可使 用^錯月鏈黴菌TK24等;於微生物宿主為屬於啤酒酵母 U生物之情形時,可使用啤酒酵母1等。 ^ 、、藉由轉形微生物製造本發明之α·半乳糖酶時, ^轉形微生物培㈣營養培養基巾,使㈣内或培養液中 法或溶菌酶等酶==等方法而採集菌體,繼而以機械方 或適當之界、、㉟該菌體,又,視需要添加咖八及, I面活性劑等而將本發明之α_半乳糖酶之水溶液 129208.doc -20- 200846472 加以展縮,或不濃縮’繼而藉由硫酸録分級分離、凝膠過 渡、親和層析等吸附層析、離子交換層析法而加以處理, 藉此可獲得純度較高之本發明之α_半乳糖酶。 轉形微生物之培養條件,可考慮到其營養生理性質而選 擇培養條件,大多情況下係於液體中進行培養,但工章上 進行深部通氣擾拌培養較為有利。作為培養基之營養源, 可廣泛使用微生物之培養中通常使用者。培養溫度可於微 =物發育且生產本發明^•半乳糖酶之範圍内進行適當改 變’於大腸桿菌之情形時,較好的是ίο至饥左右,更好 的是20至3〇°c左右。培養條件根據條件而多少有些不同, =估"'本*明之心半乳糖酶達到最高產量之時刻而於適 =候結束培㈣可,於切㈣之情料通常心越 :、:右二培養基PH值可於細菌發育且生產本發明之" 二之乾圍内進行適宜變更,於大腸桿菌之情形時,較 好的疋PH值為6至8左右。 的=本發明’於使用上述酶時,若不會抑制本發明之酶 ’則對於精製程度等並無特別限定,除了所精製之 之酶以外’亦可使用含有該酶之物質。 组=树明,可提供含有上述本發明之α_半乳糖酶之酶 酶、β葡萄::組合物中可進而含有選自例如α_葡萄糖苦 蛋白酶半乳糖酶、纖維素酶、木聚糖酶、 半乳糖二: = 聚糖酶、甘露聚糖酶、鼠李 酶、及心…_酶、果膠甲酿酶、果膠解離 來礼搪备酸解離酶中之至少—種以上之成分。 129208.doc -21 - 200846472 劑 根據本發明’可提供含有上述酶組合物之棉子糖合成試 於本叙明中,作為微生物觸媒,除了凝結芽胞桿菌 akcmhm株以外,亦可使用上述轉形體。於本發明之棉子 糖製造中所利用之微生物觸媒,可利用藉由通常之培養方 法而獲得之微生物本身,無需自微生物精製半乳糖酶。 又,視情形,亦可使用微生物培養液、微生物培養上清 液。另-方面,藉由培養法而獲得之微生物,亦可視需要 以水或緩衝液等清洗後使用。例如,可使用經培養之微生 ^之培蚕液’或藉由離心分離、緩衝進行清洗等而獲得之 ,物心W子液’使锨生物或微生物之處理物(例如微生物 ::碎物等)懸浮或溶解的水溶液,或者將微生物或微生 處理物藉由包埋法、交聯法、或载體結合法(carrier 2㈣進行固定化而成者。作為固定化時之固定化載體 的例子,可列舉··玻璃玻 坂瑪珠石夕备、聚胺基甲酸乙醋、聚丙 =胺、聚乙婦醇、卡拉膠、海藻酸,但並不限定於該 等。 人根1 康本發明,可提供使用上述本發明之α-半乳糖酶或包 2半乳糖酶之酶組合物、棉子糖合成試劑或微生物觸媒 樓子糖之製k方法。作為原料,例如可使用蔗糖及半乳 糖。於使用嚴糖及丰身丨播从达 乍為原料時,例如,自利用α-半 ^酶之脫水縮合反應之性質上來看,較好的是原料濃度 =,但若半乳糖濃度過高,則由於半乳糖分子間會產生 縮5 ’故而會抑制蔗糖與半乳糖間的脫水縮合反應,因此 129208.doc -22. 200846472 嚴糖濃度較好的是30% (w/v)〜9〇% (w/v),更好的是35% (w/v)〜80% (w/v),更好的是 4〇0/。(w/v)〜7〇% (w/v)。半乳糖 $辰度較好的疋2% (w/v)〜45% (w/v),更好的是5% (w/v)〜35% (w/v),更好的是7% (w/v)〜3〇% (w/v)。又,較 • 好的是調製為原料中之蔗糖與半乳糖均可溶之濃度。 _ 使用本發明之α-半乳糖酶或包含心半乳糖酶之酶組合物 或包含酶組合物之棉子糖合成試劑或微生物觸媒製造棉子 φ 糖時的反應溫度,自反應速度或酶之穩定性方面而言,較 好的是10〜90°C,更好的是20〜70。〇,更好的是3〇〜6(rC。 反應pH值可於廣範圍内進行調整,自酶之穩定性方面而 言,較好的是pH值為2·0〜1〇·〇,更好的是?11值為3〇〜7.5, 更好的疋3·5〜6·0。反應時間亦根據酶之使用量而有所不 同,考慮到工業利用時,通常較好的是2〇分鐘〜2〇〇小時, 更好的是6〜80小時。然而,本發明並不限定於以上之反應 條件或反應形態,可進行適當選擇。 • 於本發明中,於使用半乳糖酶或包含α-半乳糖酶之酶 組合物或包含酶組合物之棉子糖合成試劑的棉子糖合成反 應中’棉子糖於反應溶液中累積至〇. 5 %以上時,生成募糖 中之棉子糖含有率可提雨至65%以上,於更好之條件下可 • 提高至80%以上。本發明中之較高之生成寡糖中之棉子糖 含有率,亦可於棉子糖於反應溶液中累積至〇·75〇/〇以上, 進而累積至1.0%以上時實現。 又,一般而言,於使用微生物本身之棉子糖合成反應 中’由於夾雜酶之影響而導致生成寡糖中之棉子糖含有率 129208.doc -23- 200846472 較低,相對於此,使用本發明之微生物觸媒之棉子糖合成 反應中,生成寡糖中之棉子糖含有率較高。 於本發明中所得之生成寡糖中之棉子糖含有率可藉由以 下方法測定。 棉子糖合成反應結束後,藉由將反應液稀釋25倍,於 99 C下保持10分鐘,而使反應停止。反應停止後,藉由離 心分離除去微生物,使用高效液相層析儀(出^〇對所得反 應溶液進行定量。測定係使用Thermoelectr〇n公司製造之As a host microorganism to be implanted into the plastid, if the recombinant DnA can be stably and autonomously propagated, for example, when the host microorganism is a microorganism belonging to Escherichia coli, Escherichia coli BL21, Escherichia coli bL21 (DE3), and Escherichia coli BL21trxB can be used. Escherichia coli Rosetta (DE3), Escherichia coli Rosetta, Escherichia coli R〇setta (DE3) pLysS, Escherichia coli R〇Setta (DE3) PLaCl, Escherichia coli R〇settaBlue, Escherichia coli R〇setta_gann, Escherichia coli 〇rigami, large intestine Bacillus rig ji, E. coli Timer, E. coli Dm, E. coli jmi 〇 9, E. coli W3110, E. coli C6 〇〇 and the like. Further, when the microbial host is a microbe belonging to the genus Bacillus, when a microorganism such as Bacillus subtilis or Bacillus megaterium is used as the microorganism belonging to the actinomycete, the Streptomyces elegans TK24 or the like can be used; When the microbial host is a beer yeast U organism, Saccharomyces cerevisiae 1 or the like can be used. ^,, when the α-galactosidase of the present invention is produced by the transformed microorganism, the microbial culture (4) nutrient medium towel is used to collect the cells in the method of (4) or the culture medium or the enzyme such as lysozyme == Then, the mechanical solution or the appropriate boundary, 35 of the cells, and, if necessary, the addition of the coffee, the surfactant, etc., the aqueous solution of the α-galactosidase of the present invention 129208.doc -20-200846472 It is stretched, or not concentrated, and then processed by adsorption chromatography such as sulfuric acid fractionation, gel transition, affinity chromatography, or ion exchange chromatography, whereby α_half of the present invention having higher purity can be obtained. Lactase. The culture conditions of the transformed microorganisms can be selected in consideration of their nutritional and physiological properties, and in many cases, they are cultured in a liquid, but it is advantageous to carry out deep ventilation and disturbance culture on the worksheet. As a nutrient source of the culture medium, a general user in the culture of microorganisms can be widely used. The culture temperature can be appropriately changed within the range of micro-material development and production of the galactosidase of the present invention. In the case of Escherichia coli, it is preferably ίο to hungry, more preferably 20 to 3 〇 °c. about. The culture conditions are somewhat different depending on the conditions. = Estimated " 'This is the time when the galactose enzyme reaches the highest yield and ends at the appropriate time. (4) Yes, the condition of the cut (4) is usually the heart:: Right The pH of the medium can be appropriately changed in the development of bacteria and in the production of the present invention. In the case of Escherichia coli, the pH of the medium is preferably about 6 to 8. In the case of using the above-mentioned enzyme, the enzyme of the present invention is not particularly limited, and the degree of purification or the like is not particularly limited, and a substance containing the enzyme may be used in addition to the purified enzyme. Group = Shuming, an enzyme enzyme containing the above-mentioned α-galactosidase of the present invention, β grape: The composition may further comprise, for example, α-glucosidase galactosidase, cellulase, xylan Enzyme, galactose 2: = glycanase, mannanase, rhamnase, and heart..._enzyme, pectin brewing enzyme, pectin dissociation, at least one of the above-mentioned acid dissociation enzymes . 129208.doc -21 - 200846472 According to the present invention, a raffinose synthesis containing the above enzyme composition can be provided. In the present description, as a microbial catalyst, in addition to the Bacillus coagulans akcmhm strain, the above-mentioned transformant can also be used. . The microbial catalyst used in the production of the raffinose of the present invention can utilize the microorganism itself obtained by a usual culture method, and it is not necessary to purify the galactosidase from the microorganism. Further, depending on the case, a microbial culture solution or a microbial culture supernatant may be used. On the other hand, the microorganism obtained by the culture method may be washed with water or a buffer or the like as needed. For example, it can be obtained by using cultured microbial culture silkworm liquid ' or by centrifugation, buffering, etc., and the core W liquid is used to treat microorganisms or microorganisms (for example, microorganisms:: debris, etc.) An aqueous solution that is suspended or dissolved, or a microorganism or a microbial treatment is immobilized by an embedding method, a cross-linking method, or a carrier-binding method (carrier 2). As an example of an immobilized carrier during immobilization In addition, it can be mentioned, for example, glass, glass, yttrium, urethane, polypropylamine, polyglycolic acid, carrageenan, alginic acid, but it is not limited to these. An enzyme composition using the α-galactosidase or the package 2 galactosidase of the present invention, a raffinose synthesis reagent or a microbial catalyst, and a method for producing the sugar can be provided. As a raw material, for example, sucrose and a half can be used. Lactose. When using the sugar and the body to be used as a raw material, for example, from the nature of the dehydration condensation reaction using α-half enzyme, it is preferred that the concentration of the raw material =, but if the concentration of galactose is excessive High, because of the contraction between the galactose molecules 5 'There will inhibit the dehydration condensation reaction between sucrose and galactose, so 129208.doc -22. 200846472 The concentration of sugar is preferably 30% (w/v) ~ 9〇% (w / v), better It is 35% (w/v)~80% (w/v), more preferably 4〇0/.(w/v)~7〇% (w/v). 2% (w/v) ~ 45% (w/v), more preferably 5% (w/v) ~ 35% (w/v), more preferably 7% (w/v) ~ 3〇 % (w/v). Further, it is preferred to prepare a concentration in which the sucrose and galactose in the raw material are soluble. _ Use the α-galactosidase of the present invention or the enzyme composition containing cardiac galactosidase or The reaction temperature of the raffinose synthase or the microbial catalyst comprising the enzyme composition for producing cotton φ saccharide is preferably from 10 to 90 ° C, more preferably from the viewpoint of the reaction rate or the stability of the enzyme. 20~70. 〇, more preferably 3〇~6 (rC. The pH of the reaction can be adjusted in a wide range. From the aspect of stability of the enzyme, the pH is preferably 2·0~1〇 ·〇, better? The value of 11 is 3〇~7.5, and the better is 疋3·5~6·0. The reaction time also varies according to the amount of enzyme used, considering the industrial benefits. In general, it is preferably 2 to 2 hours, more preferably 6 to 80 hours. However, the present invention is not limited to the above reaction conditions or reaction forms, and can be appropriately selected. In the raffinose synthesis reaction using a galactase or an enzyme composition comprising α-galactosidase or a raffinose synthesis reagent comprising the enzyme composition, the raffinose is accumulated in the reaction solution to 〇. 5 % In the above case, the content of raffinose in the sugar-producing sugar can be increased to 65% or more, and can be increased to 80% or more under better conditions. The raffinose content in the higher oligosaccharide produced in the present invention can also be achieved when the raffinose is accumulated in the reaction solution to 〇·75〇/〇 or more and further accumulated to 1.0% or more. Further, in general, in the raffinose synthesis reaction using the microorganism itself, the raffinose content in the oligosaccharide produced by the influence of the inclusion enzyme is 129208.doc -23-200846472, and is used. In the raffinose synthesis reaction of the microbial catalyst of the present invention, the raffinose content in the oligosaccharide is high. The raffinose content in the resulting oligosaccharide obtained in the present invention can be determined by the following method. After completion of the raffinose synthesis reaction, the reaction was stopped by diluting the reaction solution by 25 times and maintaining at 99 C for 10 minutes. After the reaction was stopped, the microorganisms were removed by centrifugation, and the obtained reaction solution was quantified using a high performance liquid chromatograph. The measurement was carried out using Thermoelectr〇n.

Hypercarb管柱,檢測器係使㈣。生成募糖中之棉子糖 3有率,彳由於HPLC分析圖中檢測出之各個峰面積比, 根據(棉子糖之峰面積)/(生成募糖之峰面積)χ刚算出、。 作為將藉由本發明之方法而製造之棉子糖進行精製、分 離之方法’可利用通常所使用之精製處理方法。即,^ 如’藉由離心分離、利用MF膜或UF膜等之膜處理 =除去微生物觸媒,藉㈣離子交換層析法或陰離子交: =法等層析處理或透析等脫鹽處理,除去自緩衝典 養基等帶入之_望、隹& σ 離子,… 陽離子交換層析法、陰 ^子父換層析法、高效液相層析法、活斤 處理或利用溶解度之差等之結晶化處理、4 = Μ析 法層析處理可單獨使用該等方 :、!成t使用’可適當利用移動層式或模擬移J ί棉:Γ 擬移動層式、多成分分離循環式等= 其枝笨 <精製、分離處理方法,可分批進行,亦可利用 &柱等而連續進行。 』和用 129208.doc •24- 200846472 以下,藉由實施例進行具體說明,但本發明並不受該等 實施例之任何限制。 [實施例] 實施例1 將凝結牙胞桿_ AKC-004株(寄存編號FERM P-21092(以 FERM-ABP10948作為編號而移交管理)(台灣寄存編號: ' BCRC 9103 88);寄存機關:獨立行政法人產業技術綜合研 究所專利生物寄存中心)於胰蛋白血瓊脂基礎(Tryptose Blood Agar Base,TBAB)平板培養基(Difco)上,於 55。(:下 培養1天,而形成菌落。 將pH值調整為7.2之表1所示的培養基30 mL,加入至150 mL容量之三角燒瓶中,以鉑耳於上述平板培養基上植入 菌落,以50°C、25小時、1 80 rpm之條件進行旋轉振盪培 養,將其作為瓶中培養之種子細菌。 [表1] 表1 :培養基組成 培養基組成 微量金屬元素溶液組成Hypercarb column, detector system (4). The rate of the raffinose in the sugar collection was 3, and the area ratio of each peak detected in the HPLC analysis chart was calculated based on (the area of the peak of raffinose) / (the area of the peak of the sugar-producing sugar). As a method of purifying and separating raffinose produced by the method of the present invention, a purification treatment method generally used can be used. That is, ^ such as 'by centrifugation, membrane treatment using MF membrane or UF membrane = removal of microbial catalyst, by (4) ion exchange chromatography or anion exchange: = method such as chromatography or dialysis, etc., removal Self-buffering nurturing groups, etc., such as cation, chromatography, cation exchange chromatography, high-performance liquid chromatography, high-pressure liquid chromatography, or the difference in solubility, etc. The crystallization treatment, 4 = decantation chromatography can be used separately:,! Use t to use the movable layer or analog shift J ί cotton: 拟 moving layer type, multi-component separation cycle type, etc. = its branching < refining, separation processing method, can be carried out in batches, and can also be used & Columns and the like are continuously performed. The following is a detailed description by way of examples, but the invention is not limited by the examples. [Examples] Example 1 Coagulation of dental rod _ AKC-004 strain (registration number FERM P-21092 (transferred with FERM-ABP10948 as number) (Taiwan registration number: 'BCRC 9103 88); depository: independent The Administrative Biotechnology Industrial Technology Research Institute Patent Bioburden Center is on the Tryptose Blood Agar Base (TBAB) plate medium (Difco) at 55. (: cultured for 1 day, and colonies were formed. 30 mL of the medium shown in Table 1 adjusted to pH 7.2 was added to a 150 mL capacity Erlenmeyer flask, and the colony was implanted on the above plate medium with platinum ear to Rotary shaking culture was carried out at 50 ° C, 25 hours, and 180 rpm, and it was used as a seed bacterium cultured in a bottle. [Table 1] Table 1: Medium composition medium composition Trace metal element solution composition

棉子糖 l〇g CH3COONa 12.8 g 甘油 log FeS04*7H20 Ig 酵母萃取物 log MnCl2.4H20 0.5 g 蛋白腺 l〇g CoC12.6H20 0.3 g MgS04*7H20 0.5 g ZnS04*7H20 0.4 g CaCl2 0.04 g CuC12*2H20 50 mg 0.01 Μ之擰檬酸 0.5 mL NaMo04.2H20 50 mg 醋酸鈉三水合物 0.132 g H3BO4 20 mg ΚΗ2Ρ04 0.544 g NiCl2.6H20 20 mg Na2HP〇4*12H2〇 2.14 g 蒸餾水 1 L 微量金屬元素溶液 0.5 mL 蒸餾水 1 L 129208.doc -25 200846472 繼而,將pH值調整為7·2之表1斛-十拉总* 心衣1所不之培養基6 L,加入 至10 L容量之缸式酸醏梓φ 、職醇槽中移植上述瓶中所培養之種子 細菌15 mL,以50°C、48小時、2⑽ Λ , ^ 200 rpm、0.2 vvm之條件進 行通氣攪拌培養。 繼而,於4。(:下,對該培養液進行1〇,〇〇〇§χ3〇分鐘之離 心分離’以除去上清液,而回收菌體。測定所得菌體之… 半乳糖酶之活性,結果為261 U。Raffinose l〇g CH3COONa 12.8 g Glycerol log FeS04*7H20 Ig Yeast extract log MnCl2.4H20 0.5 g Protein gland l〇g CoC12.6H20 0.3 g MgS04*7H20 0.5 g ZnS04*7H20 0.4 g CaCl2 0.04 g CuC12*2H20 50 mg 0.01 拧 citric acid 0.5 mL NaMo04.2H20 50 mg Sodium acetate trihydrate 0.132 g H3BO4 20 mg ΚΗ2Ρ04 0.544 g NiCl2.6H20 20 mg Na2HP〇4*12H2〇2.14 g Distilled water 1 L Trace metal element solution 0.5 mL Distilled water 1 L 129208.doc -25 200846472 Then, adjust the pH to 7·2. Table 1斛-十拉总* 6 L of the culture medium of Heartcoat 1 is added to the cylinder acid 醏梓φ of 10 L capacity In the alcohol tank, 15 mL of the seed bacteria cultured in the above bottle was transplanted, and aeration agitation culture was carried out under the conditions of 50 ° C, 48 hours, 2 (10) Λ , ^ 200 rpm, and 0.2 vvm. Then, at 4. (:, the culture solution was centrifuged for 1 〇 χ χ 3 〇 3 minutes to remove the supernatant, and the cells were recovered. The activity of the luciferase was measured, and the result was 261 U. .

使該菌體懸浮於含有5〇 mMiTris_Hcl、2〇 mM之 EDTA、50 mM之葡萄糖的Lysis緩衝液(pH值8〇)中,而成 為150 mL。於4C下,對該懸浮液進行1〇,〇〇〇 gx3〇分鐘之 離心分離,以除去上清液,而回收菌體。 將經“比緩衝液清洗後之菌體再次懸浮於上述Lysis緩 衝液中,而成為150 mL。於其中添加〇 〇2〇/。之溶菌酶 (Sigma公司製造,來自印白),以37〇c、13小時、i2〇 rpm 之條件進行振盪,而進行菌體粉碎。 於4C下,對菌體粉碎後之溶液進行1〇,〇〇〇 gx3〇分鐘之 離心分離,以除去囷體殘渣,而回收上清液。 於該上清液中添加硫酸銨,以形成37·5%之飽和溶液, 於4°C下放置一晚而產生沈澱。於4°c下,進行1〇,000 gx30 分鐘之離心分離,以除去該沈澱,而回收上清液。 於該上清液中添加硫酸銨,以形成54,5%之飽和溶液, 於4°〇下放置一晚而產生沈殿。於4。(:下,進行1〇,〇〇〇&\30 分鐘之離心分離,以回收該沈澱,再將其溶解於pH值為 7.0之20 mM填酸緩衝液中,於4°C下放置一晚,對與上述 12920B.doc -26 - 200846472 相同之填酸緩衝液進行透析。 使藉由透析而獲得之上清液吸附於以與上述相同之磷酸 缓衝液進行平衡化之「DEAE Sepharose FF」(GE HEALTHCARE. BIO-SCIENCES股份有限公司)上,之後藉 由含有0〜0.4 Μ之氯化鈉之pH值為7,0的20 mM磷酸緩衝液 之濃度梯度法而使酶溶出。 β 收集上述所溶出之活性組分,使用平均截留分子量為 10,000之超濾膜進行濃縮,使其吸附於以含有2 Μ之氯化 ® 鈉之pH值為7.0的20 mM磷酸緩衝液進行平衡化之「HiTrapThe cells were suspended in Lysis buffer (pH 8 Torr) containing 5 〇 mMiTris_Hcl, 2 mM EDTA, 50 mM glucose to obtain 150 mL. The suspension was centrifuged at 4 C for 1 〇, 〇〇〇 gx3 〇 minutes to remove the supernatant, and the cells were recovered. The cells which were washed with the buffer were resuspended in the above Lysis buffer to become 150 mL, and lysozyme (manufactured by Sigma, from Imprint) was added thereto to 37 〇. c, 13 hours, i2 rpm conditions to oscillate, and the bacteria are pulverized. At 4C, the solution after the pulverization of the cells is subjected to 1 〇, 〇〇〇gx3 〇 minutes of centrifugation to remove the steroid residue, The supernatant was recovered. Ammonium sulfate was added to the supernatant to form a 37.5% saturated solution, which was allowed to stand overnight at 4 ° C to produce a precipitate. At 4 ° C, 1 〇, 000 g x 30 was carried out. The supernatant was removed by centrifugation to remove the precipitate, and ammonium sulfate was added to the supernatant to form a saturated solution of 54 and 5%, which was allowed to stand overnight at 4 ° to produce a sag. (:, 1 〇, 〇〇〇 &\30 minutes of centrifugation to recover the precipitate, and then dissolved in a pH of 7.0 20 mM acid buffer, placed at 4 ° C One night, dialysis was performed on the same acid buffer as the above 12920B.doc -26 - 200846472. The supernatant was adsorbed to "DEAE Sepharose FF" (GE HEALTHCARE. BIO-SCIENCES Co., Ltd.) equilibrated with the same phosphate buffer as above, and then passed through a pH value of sodium chloride containing 0 to 0.4 Torr. The enzyme was eluted by a concentration gradient method of 7 mM 20 mM phosphate buffer. β The above-dissolved active component was collected, concentrated using an ultrafiltration membrane having an average molecular weight cut off of 10,000, and adsorbed to contain 2 Μ. "HiTrap" for the equilibration of 20 mM phosphate buffer with a pH of 7.0 of chlorinated sodium

Phenyl FF(high sub)」(GE HEALTHCARE. BIO-SCIENCES 股份有限公司)上,之後藉由含有2.0〜0 M之氯化鈉之pH值 為7.0的20 mM磷酸緩衝液之濃度梯度法而使酶溶出。 收集上述所溶出之活性組分,使用平均截留分子量為 10,000之超濾膜進行濃縮,使其吸附於以pH值為7.0之20 mM磷酸缓衝液進行平衡化之「MonoQ 5/50 GL」(GE φ HEALTHCARE. BIO-SCIENCES股份有限公司)上,之後藉 由含有0〜0·4 Μ之氯化鈉之pH值為7.0的20 mM磷酸緩衝液 之濃度梯度法而使酶溶出。 ^ 收集上述所溶出之活性組分,使用平均截留分子量為 • 10,000之超濾膜進行濃縮,將其填充至以pH值為7.0之20 mM填酸緩衝液進行平衡化之「「HiLoad 16/60 Superdex 200」(GE HEALTHCARE. BIO-SCIENCES股份有限公司) 上,之後以同樣之緩衝液進行溶出。 收集上述所溶出之活性組分,使用平均截留分子量為 129208.doc -27- 200846472 10,000之超濾膜進行濃縮,而製成精製半乳糖酶。活性 產率為15%,活性為270 U/mL。 實施例2 使用戶、%例1所得之精製α_半乳糖酶,進行關於其作用 之實驗。 (1) 最佳pH值範圍 於溶解在各pH值之1〇〇 mM緩衝液中的6 mM之對硝基苯_ φ 心0-吡喃半礼糖苷150 ^中,混合稀釋100倍的本發明之 精衣酶液50 pL,於4〇 C下使其反應5分鐘。反應後,對游 離之對石肖基苯盼進行定量,藉此測定活性,求出將最大活 性設為100時之相對活性。將該結果示於圖1。再者,所使 用之緩衝液為甘胺酸_HC1緩衝液(pH值為2 5〜3·5)、醋酸鈉 緩衝液(pH值為3·5〜6·〇)、石舞酸納緩衝液(ρΗ值為6〇〜8·5)、 甘胺酸-NaOH緩衝液(ρΗ值為8·5〜1〇 〇)。 (2) 穩定pH值範圍 • 於pH值為4·0〜10·〇之範圍内使用10 mM之緩衝液,於各 pH值下進仃45 C、140分鐘之加熱處理,再測定其殘留活 性,與上述同樣地求出將最大活性設為1〇〇時之相對活 性。將其結果示於圖2。再者,所使用之各pH值之緩衝液 ’ 的種類係與上述相同。 (3) 最佳溫度範圍 於溶解在pH值為4.5之醋酸鈉緩衝液中之47 mM之對硝 基苯-a-D-吼喃半乳糖苷190吣中,混合稀釋2〇倍的本發明 之精製酶液10卟,於20〜6(TC之範圍内使其反應5分鐘。 129208.doc -28 - 200846472 反應後,對游離之對硝基苯盼進行定量,藉此測定活性, 求出將最大活性設為1 00時之相對活性。將其結果示於圖 3 ° (4) 穩定溫度範圍 使用pH值為4.5之100 mM醋酸納缓衝液,於30〜55°C之 各溫度下進行20分鐘之加熱處理,測定其殘留活性,與上 述同樣地求出將最大活性設為1〇〇時之相對活性。將其結 果示於圖4。 (5) 分子量 藉由使用分離凝膠濃度為10%之r Ready Gels J」(曰本Phenyl FF (high sub)" (GE HEALTHCARE. BIO-SCIENCES Co., Ltd.), followed by concentration gradient method using a concentration gradient of 2.0 mM phosphate buffer containing 2.0 to 0 M of sodium chloride Dissolution. The above-dissolved active components were collected, concentrated using an ultrafiltration membrane having an average molecular weight cut off of 10,000, and adsorbed to "MonoQ 5/50 GL" (GE) equilibrated with 20 mM phosphate buffer having a pH of 7.0. φ HEALTHCARE. BIO-SCIENCES Co., Ltd.), and then the enzyme was eluted by a concentration gradient method of 20 mM phosphate buffer containing pH 7.0 of 0 to 0.4 Μ. ^ Collect the above-dissolved active components, concentrate them with an ultrafiltration membrane with an average molecular weight cut off of 10,000, and fill them with "HiLoad 16/60" equilibrated with 20 mM acid buffer buffer at pH 7.0. Superdex 200" (GE HEALTHCARE. BIO-SCIENCES Co., Ltd.) was dissolved in the same buffer. The above-dissolved active component was collected and concentrated using an ultrafiltration membrane having an average molecular weight cut off of 129208.doc -27-200846472 10,000 to prepare a purified galactosease. The activity yield was 15% and the activity was 270 U/mL. Example 2 The user and the purified α-galactosidase obtained in % of Example 1 were subjected to an experiment on the action thereof. (1) The optimum pH range is 6 mM p-nitrobenzene _ φ heart 0-pyranose 150 ^ dissolved in 1 mM buffer of each pH value, mixed and diluted 100 times The purified enzyme solution of the invention was 50 pL and allowed to react at 4 ° C for 5 minutes. After the reaction, the amount of the free pair of schiff base was determined, and the activity was measured to determine the relative activity when the maximum activity was 100. This result is shown in FIG. Further, the buffer used is glycine _HC1 buffer (pH 2 5 to 3 · 5), sodium acetate buffer (pH 3·5 〜 6 · 〇), and sulphate buffer Liquid (ρΗ value is 6〇~8·5), glycine-NaOH buffer (ρΗ value is 8·5~1〇〇). (2) Stable pH range • Use 10 mM buffer at pH value of 4·0~10·〇, heat treatment at 45 ° C for 140 minutes at each pH value, and measure residual activity. The relative activity when the maximum activity was 1 求出 was determined in the same manner as above. The results are shown in Fig. 2. Further, the types of buffers used for each pH value are the same as described above. (3) The optimum temperature range is 47 mM p-nitrophenyl-aD-galactopyranoside 190吣 dissolved in a pH 4.5 sodium acetate buffer, mixed and diluted 2 times the purification of the present invention The enzyme solution was 10 Torr and allowed to react for 5 minutes in the range of 20 to 6 (TC 129208.doc -28 - 200846472. After the reaction, the free p-nitrobenzene was quantified, thereby measuring the activity and determining the maximum. The activity is set to the relative activity at 100 ° C. The results are shown in Figure 3 ° (4) Stable temperature range using 100 mM sodium acetate buffer at pH 4.5, at 20 ° C to 55 ° C for 20 minutes The heat treatment was carried out, and the residual activity was measured, and the relative activity when the maximum activity was 1 Torr was determined in the same manner as above. The results are shown in Fig. 4. (5) The molecular weight was 10% by using a separation gel. r Ready Gels J" (曰本

Bio-Rad Laboratories股份有限公司)之sdS-聚丙烯醯胺凝 膠電泳,求出分子量。將其結果示於圖5。分子量約為 80,〇〇〇,與由胺基酸序列推算之分子量83,122基本一致。 (7)受質特異性 於含有10 mM之各種受質的pH值為45之1〇〇 mM醋酸鈉 緩衝液150 pL中,混合稀釋1〇〇倍的本發明之精製酶液5〇 KL於40 C下使其反應20分鐘。其中,將對硝基苯_a_D_ 吼畴半乳糖苷用於受質之反應中,將反應時間設為5分 鐘。反應後’㈣離之對硝基苯料行定量,或根據藉由 使用「Shodex SUGAR」(昭和電工股份公司)管柱之高效液 相層析儀之分析’對分解之受質進行定量,求出將最大活 性設為100時各受質之相對活性。將其結果示於表2。又, 其中’對形成受質者測定反應速度,將結果示於表3。 129208.doc -29- 200846472 [表2] 表2 : α-半乳糖酶之受質特異性 基質 相對活性 ρΝΡ-α-°比喃半乳糖苷 100 ρΝΡ-β-吼味半乳糖苦 0 棉子糖 10 蜜二糖 38 乳糖 0 蔗糖 0 [表3] 表3 : α-半乳糖酶之反應速度常數 基質 Km(mM) Vmax(U/mg) ρΝΡ-α-σ比喃半乳糖苷 0.53 82 棉子糖 40 48 蜜二糖 8.4 106 (8)抑制因素 於溶解在pH值為4.5之醋酸鈉緩衝液中之6 mM之對硝基 苯-α-D-吡喃半乳糖苷中,以最終濃度達到1 mM之方式添 加各種金屬離子,而成為150 μ[,再混合稀釋100倍的本 發明之精製酶液50 gL,於40°C下使其反應20分鐘。反應 後,對游離之對硝基苯酚進行定量,藉此測定活性,而求 出將最大活性設為100時之相對活性。將其結果示於表4。 [表4] 表4 :金屬鹽對a-半乳糖酶之抑制 金屬離子 相對活性 對照 100 鉀 97 鈣 97 129208.doc -30- 200846472 鎂 95 鉻 99 猛 95 鐵(II) 98 鐵(III) 99 鈷 95 鎳 88 銅 33 鋅 80 實施例3 分別取出實施例1中記載之精製α-半乳糖酶0.5 U,將其 添加至裝入1.5 mL容量之聚丙烯製試管中的200 pL之糖液 (pH值5.0之100 mM醋酸鈉緩衝液中含有蔗糖73%、半乳糖 12%)中,並進行混合,以60°C、1,200 rpm之條件使其反 應。自反應開始經過45小時後,自反應液中取出20 μ!^, 以480 μί蒸餾水進行稀釋後,於99°C下處理10分鐘,藉此 使酶熱失活。使熱失活後之稀釋糖液恢復至常溫後,藉由 使用「Hyp ere arb」(Thermo electron公司製造)管柱之高效 液相層析儀進行分析。將其結果示於圖6。生成寡糖中之 棉子糖含有率為82%,反應液中之棉子糖濃度為1.67重量 %。 實施例4 (1)染色體DNA之製備 依據常法,製備凝結芽胞桿菌AKC-004株之染色體 DNA。對藉由實施例1中所記載之方法而獲得之凝結芽胞 桿菌AKC-004株之培養液60 mL進行離心分離,回收菌 體。使所得菌體懸浮於Lysis緩衝液(50 mM Tris-HCl(pH值 129208.doc •31 - 200846472 為8.0)、20 mM之EDTA、50 mM葡萄糖)中,再充分清洗。 進行離心分離,而回收菌體後,再次將其懸浮於Lysis緩衝 液中,於其中添加溶菌酶,於3 7 °C下培養4 5分鐘。繼而, 添加SDS及RNase,於37°C下培養45分鐘。其後添加蛋白 酶K(Proteinase K),於50°C下穩定振盪60分鐘。以苯酚-氯 仿、氯仿,對此處所獲得之溶液進行處理後,進行乙醇沈 澱,將所析出之核酸纏繞在玻璃吸管上,而加以回收。以 70%乙醇對該核酸進行清洗後,加以乾燦,再將其溶解於 ΤΈ中。藉由該操作,製備約1 mg之染色體DNA。 (2) α -半乳糖酶基因之離析 由上述(1)中所製備之染色體DNA,設計、合成用以增 幅α-半乳糖酶基因片段之PCR引子。引子之設計係以眾所 周知之來自數種微生物之α-半乳糖酶基因之比對結果為基 礎而進行,同義引子合成具有 5’-GAAGTITACGGITTYAGYYTTGTITACAGYGG-3’(序列編號 3)之序列的寡聚DNA ,反義引子合成具有5’· CCAAACCAICCRTCRTCIARIACRAA-3,(序歹U 編號 4)之序歹ij 的寡聚DNA。再者,序列中,I表示肌苷,Y表示C或T,R 表示A或G。使用此處所得之PCR引子,以上述(1)中所製 備之染色體DNA作為模板,藉由PCR法進行α-半乳糖酶基 因片段之增幅,而獲得含有380個鹼基對之α-半乳糖酶基 因片段。使用DNA測序儀對此處所得之基因片段之鹼基序 列加以分析。 為了獲取含有α-半乳糖酶基因全長之DNA片段,以由分 129208.doc -32- 200846472 析所得之α-半乳糖酶基因片段之驗基序列作為基礎,而設 計、合成反向PCR用PCR引子。同義引子合成具有5’-TGATCAACAACTGGGAAAGCGACCT-3,(序歹丨J 編號 5)之序 列的寡聚DNA , 反義引子合成具有5’-GAACTGGTCCTGCTGCACAATTCC-3f(序歹編號 6)之序歹 的募聚DNA。繼而,製備用於反向PCR之模板。以制限酶 Hindlll ’將上述(1)中所製備之染色體DNA消化後,使用 T4 DNA連接酶(T4 DNA Ligase)使所得DNA片段自身環 化,而形成反向PCR之模板。針對該模板,使用如上述般 合成之反向PCR用引子,藉由PCR法對包含α-半乳糖酶基 因之DNA片段進行增幅,獲取含有α·半乳糖酶基因之全部 序列的包含4500個驗基對的PCR產物。 (3)鹼基序列之分析 使用DNA測序儀,由(2)中所得之PCR產物決定α-半乳糖 酶基因之鹼基序列。其結果為,解碼出具有自序列編號i 所示之5’末端起之DNA鹼基序列之2190個鹼基對的α-半乳 糖酶之結構基因。該序列係從未發現之新穎基因。又,由 該DNA鹼基序列類推之凝結芽胞桿菌AKC-004株所生產之 α-半乳糖酶包含730個胺基酸,具有序列編號2所示之自Ν 末端起之胺基酸序列。檢索資料庫,結果發現,該胺基酸 序列與來自嗜熱桿菌牙抱(Geobacillus stearothermophilus) 之α-半乳糖酶(AgaN)具有57%之同源性,與來自嗜熱桿菌 芽孢之α-半乳糖酶(AgaA)具有56%之同源性,與來自嗜熱 桿菌芽孢之a半乳糖酶(AgaB)具有56%之同源性,與來自棉 129208.doc •33- 200846472 子糖乳球菌(Lactococcus raffinolactis)之α-半乳糖酶具有 56%之同源性,明確其係編碼新穎之α-半乳糖酶。 (4)α-半乳糖酶基因之表現質體載體之構建及轉形 以(3)中所得之α-半乳糖酶基因之序列為基礎,設計、合 成用以增幅包含α-半乳糖酶基因之SD序列、結構基因、終 止密碼子之區域的PCR引子。PCR引子之設計係以(2)中所 得之包含4500個鹼基對之PCR產物的鹼基序列為基礎而進 行,同義引子合成具有 5*-TAAGGTAAAGCAGATGTGCCATT-3’ (序列編號7)之序列的寡聚DNA,反義引子合成具有5f-TTACTCGTACACCGCCTC-3,(序歹編號8)之序歹》J的寡聚 DNA。以(2)中所得之包含4500個鹼基對之PCR產物為模 板,使用合成之PCR引子,藉由PCR法進行增幅,而獲取 包含2325個鹼基對之PCR產物。將此處所得之PCR產物末 端平滑化、磷酸化。於藉由制限酶EcoRV進行消化後,再 進行脫填酸化而成的pBluescriptll KS(+)載體上,連接上 述所得之經末端平滑化、磷酸化之PCR產物,構建新的質 體載體pBlue/agaA。該質體載體中導入有可有效轉錄在大 腸桿菌内作為外來基因而連接之基因的lac啟動子,可有效 表現/製造α-半乳糖酶。將所得質體載體於以氯化鈣法製備 之大腸桿菌JM109株之勝任細胞中,藉由熱震法進行轉轉 形,而製作重組微生物。 (5)轉形體之培養及α·半乳糖酶之表現 將(4)中所製作之重組大腸桿菌JM109-pBlue/agaA,於含 129208.doc -34- 200846472 有100 mg/L之安比西林的30 mL之養基中,於下 振盪培養24小時。培養後,對重組大腸桿菌進行離心分 離,而將其回收。以100 mM醋酸鈉緩衝液(pH值為5〇)對 菌體進行清洗後,再次將其懸浮於相同之緩衝液中,藉由 超音波粉碎機進行粉碎。藉由上述方法測定該粉碎液之心 半乳糖酶活性,結果為1991;/培養液(mL)。 實施例5 分別取出培養實施例4中所記載之重組體而獲得之心半 乳糖酶ι·ο u,添加至裝入丨.5 mL容量之聚丙烯製試管中之 200 μί之糖液(pH值為5 〇之1〇〇 mM醋酸鈉緩衝液中含有蔗 糖73%、半乳糖12%)中,並進行混合,以6〇它、〗,2〇〇卬㈤ 之條件進行反應。自反應開始經過16小時後,自反應液中 取出20 pL,以480 pL蒸餾水進行稀釋後,於99它下處理1〇 分鐘,藉此使酶熱失活。使熱失活後之稀釋糖液恢復至常 ’皿後藉由使用「Hypercarb」(Thermoelectron公司製造) 管柱之高效液相層析儀進行分析。將其結果示於圖7。生 成养糖中之棉子糖含有率為82%,反應液中之棉子糖濃度 為1.20重量%。 實施例6 將凝結芽胞桿菌AKC-004株(寄存編號FERM P-21〇92(以 FERM-ABPl〇948之編號移交管理)(台灣寄存編號:BCRc 910388) ’寄存機關·獨立行政法人產業技術綜合研究所 專利生物寄存中心)於胰蛋白血瓊脂基礎(Trypt〇se B1〇〇d Agar Base,TBAB)平板培養基(Difc〇)上,於55。〇下培養i 129208.doc •35- 200846472 天,形成菌落。將其1鉑耳接種至將表1所示之培養基3〇 mL分注於15〇 mL容量之三角燒瓶而成者上,以55C、150 rpm之條件培養2天。Bio-Rad Laboratories, Inc.) sdS-polyacrylamide gel electrophoresis to determine the molecular weight. The result is shown in Fig. 5. The molecular weight is about 80, 〇〇〇, which is substantially identical to the molecular weight 83,122 estimated from the amino acid sequence. (7) The specificity is 5 〇KL of the purified enzyme solution of the present invention diluted and diluted 1 〇〇 in a 150 mM mM sodium acetate buffer having a pH of 45 mM containing various contents of 10 mM. The reaction was allowed to proceed for 20 minutes at 40 C. Among them, p-nitrobenzene_a_D_ domain galactoside was used in the reaction of the host, and the reaction time was set to 5 minutes. After the reaction, (4) the amount of the p-nitrobenzene material is quantified, or according to the analysis of the high-performance liquid chromatograph by using the column of "Shodex SUGAR" (Showa Denko Co., Ltd.) The relative activity of each substrate when the maximum activity was set to 100. The results are shown in Table 2. Further, where the reaction rate was measured for the recipient of the formation, the results are shown in Table 3. 129208.doc -29- 200846472 [Table 2] Table 2: Relative activity of α-galactosidase-specific matrix ρΝΡ-α-° than galactoside 100 ρΝΡ-β-吼 galactose bitter 0 cottonseed Sugar 10 Honey disaccharide 38 Lactose 0 Sucrose 0 [Table 3] Table 3: Reaction rate constant of α-galactosidase Matrix Km (mM) Vmax (U/mg) ρΝΡ-α-σ galactoside 0.53 82 Cotton Glycogen 40 48 melibiose 8.4 106 (8) Inhibitory factor in 6 mM p-nitrophenyl-α-D-galactopyranoside dissolved in pH 4.5 sodium acetate buffer to final concentration Various metal ions were added so as to be 1 mM, and 150 μL was added, and 50 g of the purified enzyme solution of the present invention diluted 100 times was mixed, and reacted at 40 ° C for 20 minutes. After the reaction, the free p-nitrophenol was quantified to measure the activity, and the relative activity at which the maximum activity was set to 100 was determined. The results are shown in Table 4. [Table 4] Table 4: Metal salt inhibition of a-galactosidase metal ion relative activity control 100 potassium 97 calcium 97 129208.doc -30- 200846472 magnesium 95 chromium 99 violent 95 iron (II) 98 iron (III) 99 Cobalt 95 Nickel 88 Copper 33 Zinc 80 Example 3 The purified α-galactosidase 0.5 U described in Example 1 was separately taken out and added to a 200 pL sugar liquid in a 1.5 mL-capacity polypropylene test tube ( The pH 5.0 of 100 mM sodium acetate buffer contained 73% sucrose and 12% galactose, and the mixture was mixed, and the reaction was carried out at 60 ° C and 1,200 rpm. After 45 hours from the start of the reaction, 20 μM was taken out from the reaction solution, diluted with 480 μL of distilled water, and then treated at 99 ° C for 10 minutes to inactivate the enzyme heat. After the heat-inactivated diluted sugar liquid was returned to normal temperature, it was analyzed by a high performance liquid chromatography using a "Hyp ere arb" (manufactured by Thermo Electro) column. The result is shown in Fig. 6. The raffinose content in the oligosaccharide was 82%, and the raffinose concentration in the reaction solution was 1.67 wt%. Example 4 (1) Preparation of chromosomal DNA Chromosomal DNA of Bacillus coagulans AKC-004 strain was prepared according to a usual method. 60 mL of the culture solution of the B. coagulans AKC-004 strain obtained by the method described in Example 1 was centrifuged to collect the cells. The obtained cells were suspended in Lysis buffer (50 mM Tris-HCl (pH 129208.doc • 31 - 200846472: 8.0), 20 mM EDTA, 50 mM glucose), and then thoroughly washed. After centrifugation, the cells were recovered, suspended again in Lysis buffer, lysozyme was added thereto, and cultured at 37 ° C for 45 minutes. Then, SDS and RNase were added and cultured at 37 ° C for 45 minutes. Thereafter, proteinase K (Proteinase K) was added, and the mixture was stably shaken at 50 ° C for 60 minutes. After the solution obtained here was treated with phenol-chloroform and chloroform, ethanol precipitation was carried out, and the deposited nucleic acid was wound around a glass pipette and recovered. The nucleic acid was washed with 70% ethanol, dried, and dissolved in mash. By this operation, about 1 mg of chromosomal DNA was prepared. (2) Isolation of α-galactosidase gene The PCR primer for amplifying the α-galactosidase gene fragment was designed and synthesized from the chromosomal DNA prepared in the above (1). The design of the primer is based on the well-known results of the α-galactosidase gene from several microorganisms, and the oligo DNA having the sequence of 5'-GAAGTITACGGITTYAGYYTTGTITACAGYGG-3' (SEQ ID NO: 3) is synthesized by synonymous primer. The antisense primer synthesizes an oligo DNA having the sequence 歹 ij of 5'·CCAAACCAICCRTCRTCIARIACRAA-3, (Sequence 歹U number 4). Further, in the sequence, I represents inosine, Y represents C or T, and R represents A or G. Using the PCR primer obtained here, the chromosomal DNA prepared in the above (1) was used as a template, and the α-galactosidase gene fragment was amplified by PCR to obtain α-galactose containing 380 base pairs. Enzyme gene fragment. The base sequence of the gene fragment obtained here was analyzed using a DNA sequencer. In order to obtain a DNA fragment containing the full length of the α-galactosidase gene, PCR for reverse PCR was designed based on the sequence of the α-galactosidase gene fragment obtained from the analysis of 129208.doc -32-200846472. Introduction. Synthetic primers were used to synthesize oligo DNA with the sequence of 5'-TGATCAACAACTGGGAAAGCGACCT-3, (Sequence 歹丨 J No. 5), and antisense primers were used to synthesize the DNA of the sequence with 5'-GAACTGGTCCTGCTGCACAATTCC-3f (Sequence No. 6). . Then, a template for reverse PCR was prepared. The chromosomal DNA prepared in the above (1) was digested with the restriction enzyme Hindlll', and the resulting DNA fragment was itself cyclized using T4 DNA ligase (T4 DNA Ligase) to form a template for reverse PCR. For the template, the DNA fragment containing the α-galactosidase gene was amplified by PCR using the primer for reverse PCR synthesized as described above, and 4,500 assays containing the entire sequence of the α-galactosidase gene were obtained. Base pair PCR product. (3) Analysis of base sequence The base sequence of the α-galactosidase gene was determined from the PCR product obtained in (2) using a DNA sequencer. As a result, a structural gene of 2190 base pairs of α-galactosidase having a DNA base sequence from the 5' end shown by SEQ ID NO: 1 was decoded. This sequence is a novel gene that has never been discovered. Further, the α-galactosidase produced by the B. coagulans AKC-004 strain derived from the DNA base sequence contains 730 amino acids, and has an amino acid sequence from the quinone terminal shown by SEQ ID NO: 2. The database was searched and it was found that the amino acid sequence has 57% homology with α-galactosidase (AgaN) from Geobacillus stearothermophilus, and α-half from Thermomyces sp. Lactase (AgaA) has 56% homology with 56% homology to a galactosidase (AgaB) from Bacillus thermophilus, and from 129208.doc •33-200846472 Lactococcus lactis ( The α-galactosidase of Lactococcus raffinolactis has 56% homology, which is clearly encoded by the novel α-galactosidase. (4) Expression of α-galactosidase gene Construction and transformation of the plastid vector based on the sequence of the α-galactosidase gene obtained in (3), designed and synthesized to increase the alpha-galactosidase gene PCR primers for the region of the SD sequence, structural gene, and stop codon. The design of the PCR primer was based on the base sequence of the PCR product containing 4,500 base pairs obtained in (2), and the synonymous primer was used to synthesize the sequence having the sequence of 5*-TAAGGTAAAGCAGATGTGCCATT-3' (SEQ ID NO: 7). Poly DNA, antisense primers were used to synthesize oligo DNA with 5f-TTACTCGTACACCGCCTC-3, (Sequence No. 8). The PCR product containing 4,500 base pairs obtained in (2) was used as a template, and the PCR product was amplified by PCR using a synthetic PCR primer to obtain a PCR product containing 2325 base pairs. The PCR product obtained at the end of the PCR product was smoothed and phosphorylated. After digestion with the restriction enzyme EcoRV, the de-acidified pBluescriptll KS(+) vector was ligated to the terminal smoothed and phosphorylated PCR product to construct a new plastid vector pBlue/agaA. . A lac promoter which can efficiently transcribe a gene which is ligated as a foreign gene in Escherichia coli is introduced into the plastid vector, and α-galactosidase can be efficiently expressed/manufactured. The resulting plasmid vector was transformed into a competent cell of Escherichia coli JM109 strain prepared by the calcium chloride method by thermal shock method to prepare a recombinant microorganism. (5) Culture of transformant and expression of α-galactosidase The recombinant Escherichia coli JM109-pBlue/agaA prepared in (4) has 100 mg/L of ampicillin in 129208.doc -34-200846472 In a 30 mL nutrient medium, culture under shaking for 24 hours. After the cultivation, the recombinant Escherichia coli was centrifuged and recovered. After the cells were washed with 100 mM sodium acetate buffer (pH 5 〇), they were again suspended in the same buffer and pulverized by an ultrasonic pulverizer. The galactose activity of the pulverized liquid was measured by the above method, and as a result, it was 1991; / culture solution (mL). Example 5 The cardiac galactosidase ι·ο u obtained by culturing the recombinant body described in Example 4 was separately taken and added to a 200 μί sugar liquid (pH) in a polypropylene tube filled with 丨5 mL capacity. The value was 5 〇 in 1 mM sodium acetate buffer containing 73% sucrose and 12% galactose, and mixed, and the reaction was carried out under the conditions of 6 Å, 〖, 2 〇〇卬 (5). After 16 hours from the start of the reaction, 20 pL was taken out from the reaction liquid, diluted with 480 pL of distilled water, and treated at 99 for 1 minute, whereby the enzyme was heat-inactivated. The diluted sugar solution after the heat inactivation was returned to the usual dish and analyzed by a high performance liquid chromatograph using a "Hypercarb" (manufactured by Thermoelectron) column. The result is shown in Fig. 7. The raffinose content in the produced sugar was 82%, and the raffinose concentration in the reaction solution was 1.20% by weight. Example 6 Bacillus coagulans AKC-004 (registered number FERM P-21〇92 (transferred by the number of FERM-ABPl〇948) (Taiwan registered number: BCRc 910388) The Institute's patented biological deposit center was placed on Tryp〇se B1〇〇d Agar Base (TBAB) plate medium (Difc®) at 55. Underarm cultivation i 129208.doc •35- 200846472 days, colonies formed. One platinum ear was inoculated to a trifluoro flask having a volume of 15 〇 mL, and the medium shown in Table 1 was dispensed and cultured at 55 C and 150 rpm for 2 days.

本培養進行2天後,將10 mL量的培養菌體回收至i5 mL 容量之試管中。對回收有培養液之15 mL容量之試管,以 10000 rpm進行離心後,除去上清液。繼而,添加1〇〇 mM 醋酸鈉緩衝液(pH值為5.0)1 mL,使之再懸浮後,將懸浮 液移至2 mL容量之聚丙烯製試管中。再次對試管進行離 心,除去上清液後,添加300叫之糖液(pH值為5 〇之〗⑽ mM醋酸鈉緩衝液中含有蔗糖62·5%、半乳糖12 5%),藉由 旋渦混合器使菌體充分懸浮,而使糖合成反應開始進行。 本糖合成反應之反應溫度為6(^c,旋轉速度為12〇〇印㈤。 糖合成反應開始16小時後,回收反應液4〇 ,將其與96〇 pL蒸餾水充分混合,於99°C下進行1〇分鐘之酶的熱失活。 使本稀釋糖液恢復至常溫後,藉由使用「Hypercarb」 (Thermoelectron公司製造)管柱之高效液相層析儀進行分 析,將結果示於圖8。生成寡糖中之棉子糖含有率為 80%(反應液中之棉子糖濃度為〇·7〇重量〇/〇)。 實施例7 將凝結芽胞桿菌AKC-003株(寄存編號PERM Ρ-21091 ; 寄存機關:獨立行政法人產業技術綜合研究所專利生物寄 存中心)於胰蛋白jk壤脂基礎(Trypt〇Se Blood Agar Base, TBAB)平板培養基(Difco)上,於55t:下培養1天,而形成 &落。將其1翻耳接種至將表1所示之培養基3 〇 mL分注於 129208.doc -36- 200846472 150 mL容量之三角燒瓶而成者上,以55。〇、15〇 rpm之條 件培養2天。After 2 days of the culture, a 10 mL amount of the cultured cells was recovered into a test tube of i5 mL capacity. The supernatant was removed by centrifugation at 10,000 rpm in a test tube having a volume of 15 mL of the culture solution. Then, 1 mL of 1 mM sodium acetate buffer (pH 5.0) was added, and after resuspending, the suspension was transferred to a 2 mL polypropylene tube. Centrifuge the tube again, remove the supernatant, add 300 sugar solution (pH 5 〗 (10) mM sodium acetate buffer containing 62.5% sucrose, galactose 12 5%), by vortex The mixer allows the cells to be fully suspended, and the sugar synthesis reaction begins. The reaction temperature of the sugar synthesis reaction is 6 (^c, the rotation speed is 12 〇〇 printing (5). After 16 hours from the start of the sugar synthesis reaction, the reaction liquid is recovered 4 〇, and it is thoroughly mixed with 96 〇pL distilled water at 99 ° C. The heat inactivation of the enzyme was carried out for 1 minute. After the diluted sugar solution was returned to normal temperature, the sample was analyzed by a high performance liquid chromatography using a "Hypercarb" (manufactured by Thermoelectron) column, and the results are shown in the figure. 8. The raffinose content in the oligosaccharide was 80% (the raffinose concentration in the reaction solution was 〇·7 〇 weight 〇/〇). Example 7 Bacillus coagulans AKC-003 strain (registered number PERM) Ρ-21091 ; The depository authority: Patent Bioburden Center of the Institute of Industrial Technology, Independent Legal Corporation, is cultured on the Trypt〇Se Blood Agar Base (TBAB) plate medium (Difco) at 55t: Days, and formed & drop 1 inoculation to the medium shown in Table 1 3 〇 mL was dispensed into the 129208.doc -36-200846472 150 mL capacity flask, to 55. The culture was carried out for 2 days under conditions of 15 rpm.

本培養進行2天後,將1〇 mL量的培養菌體回收至i5 mL 容量之試管中。對回收有培養液之15 mL容量之試管以 loooo rpm進行離心後,除去上清液。繼而,添加1〇〇 mM 醋酸鈉緩衝液(PH值為5·0)1 mL,使之再懸浮後,將懸浮 液移至2 mL容量之聚丙烯製試管中。再次對試管進行離 心,除去上清液後,添加300吣之糖液(pH值為5 〇之1〇〇 mM醋酸鈉緩衝液中含有蔗糖62·5%、半乳糖12 5%),藉由 旋渦混合器使菌體充分懸浮,而使糖合成反應開始進行。 本糖合成反應之反應溫度為6(^c,旋轉速度為12〇〇邛㈤。 糖合成反應開始38小時後,回收反應液4〇 ,將其與96〇 μί蒸餾水充分混合,於99^下進行1〇分鐘之酶的熱失活。 使本稀釋糠液恢復至常溫後,藉由使用「Hypercarb」 (Thermoelectron公司製造)管柱之高效液相層析儀進行分 析、、Ό果為,生成养糖中之棉子糖含有率為8〇〇/0(反應液中 之棉子糖濃度為0.76重量%)。 實施例8 將减結芽胞桿菌AKC-005株(寄存編號fERM Ρ-21093 ; 寄存機關:獨立行政法人產業技術綜合研究所專利生物寄 存中心)於胰蛋白血瓊脂基礎(Trypt〇Se B1〇〇d Agar Base, TBAB)平板培養基(Difc〇)上,於55它下培養!天,而形成 囷洛。將其1鉑耳接種至將表!所示之培養基3〇 mL分注於 1 5〇 谷畺之二角燒瓿而成者上,以55 °C、150 rpm之條 129208.doc -37- 200846472 件培養2天。Two days after the culture was carried out, 1 μmL of the cultured cells were recovered into a test tube of i5 mL capacity. The supernatant was removed by centrifuging the 15 mL-capacity tube in which the culture solution was recovered at loooo rpm. Then, 1 mL of 1 mM sodium acetate buffer (pH 5.00) was added, and after resuspending, the suspension was transferred to a 2 mL-capacity polypropylene tube. The tube was centrifuged again, and after removing the supernatant, 300 ounces of sugar solution (pH 51 〇〇 mM sodium acetate buffer containing 62.5% sucrose and galactose 12 5%) was added. The vortex mixer allows the cells to be fully suspended, and the sugar synthesis reaction begins. The reaction temperature of the sugar synthesis reaction is 6 (^c, the rotation speed is 12 〇〇邛 (5). After 38 hours from the start of the sugar synthesis reaction, the reaction liquid is recovered 4 〇, and it is thoroughly mixed with 96 〇 μί distilled water, under 99 ^ The thermal inactivation of the enzyme is carried out for 1 minute. After the diluted mash is returned to the normal temperature, the sample is analyzed by a high performance liquid chromatography using a "Hypercarb" (manufactured by Thermoelectron) column, and the result is generated. The raffinose content in the nourishing sugar was 8〇〇/0 (the raffinose concentration in the reaction solution was 0.76% by weight). Example 8 Bacillus anaterium strain ACK-005 (registered number fERM Ρ-21093; The depository institution: the Patent and Bioburden Center of the Institute of Industrial Technology and Technology, the Independent Administrative Corporation, is cultured on the Trypt〇Se B1〇〇d Agar Base (TBAB) plate medium (Difc〇) at 55. Into the formation of 囷洛. Inoculate 1 platinum ear to the table! The medium shown in the table 3〇mL is dispensed into the 15 glutinous rice dumplings, at 55 ° C, 150 rpm 129208.doc -37- 200846472 pieces cultured for 2 days.

本培養進行2天後,將10 mL量的培養菌體回收至i5瓜匕 容量之試管中。對回收有培養液之15 mL容量之試管以 10000 rpm進行離心後,除去上清液。繼而,添加1〇〇 mM • 醋酸鈉緩衝液(pH值5.0)1 mL,使之再懸浮後,將懸浮液 • 移至2 mL容量之聚丙烯製試管中。再次對試管進行離心, 除去上清液後,添加300 pL之糖液(PH值為5.〇之1〇〇 mM醋 _ 酸鈉緩衝液中含有蔗糖62.5%、半乳糖12.5%),藉由旋渦 混合斋使菌體充分懸浮,而使糖合成反應開始進行。本糖 合成反應之反應溫度為6ΌΤ:,旋轉速度為12⑽rpm。糖合 成反應開始38小時後,回收反應液4〇 ,將其與960叫 療餾水充分混合’於99°C下進行1 〇分鐘之酶的熱失活。使 本稀釋糖液恢復至常溫後,藉由使用「Hypercarb」 (Thermoelectron公司製造)管柱之高效液相層析儀進行分 析’結果為,生成募糖中之棉子糖含有率為91%(反應液中 馨之棉子糖濃度為0.32重量%)。 實施例9 將凝結芽胞桿菌AKC_006株(寄存編號FERM P-21094 ; 寄存機關:獨立行政法人產業技術綜合研究所專利生物寄 存中心)於胰蛋白血壤脂基礎(Tryptose Blood Agar Base, TBAB)平板培養基(Difco)上,於55它下培養1天,而形成 菌落。將其1鉑耳接種至將表1所示之培養基30 mL分注於 150 mL谷置之二角燒瓶而成者上,以55。〇、150 rpm之條 件培養2天。 129208.doc •38- 200846472 本培養進行2天後,將10 mL量的培養菌體回收至1 5 mL 容量之試管中。對回收有培養液之15 mL容量之試管以 10000 rpm進行離心後,除去上清液。繼而,添加100 mM 醋酸鈉緩衝液(pH值5.0)1 mL,使之再懸浮後,將懸浮液 移至2 mL容量之聚丙烯製試管中。再次對試管進行離心, 除去上清液後,添加300 pL之糖液(pH值為5,0之100 mM醋 酸鈉緩衝液中含有蔗糖62.5%、半乳糖12.5%),藉由旋渦 混合器使菌體充分懸浮,而使糖合成反應開始進行。本糖 合成反應之反應溫度為60°C,旋轉速度為1200 rpm。糖合 成反應開始3 8小時後,回收反應液40 pL,將其與960 pL 蒸餾水充分混合,於99°C下進行10分鐘之酶的熱失活。使 本稀釋糖液恢復至常溫後,藉由使用「Hypercarb」 (Thermoelectron公司製造)管柱之高效液相層析儀進行分 析,結果為,生成募糖中之棉子糖含有率為76°/〇(反應液中 之棉子糖濃度為(K86重量%)。 [產業上之可利用性] 藉由使用本發明,可提供一種可使用廉價原料,而選擇 性製造棉子糖之方法。 【圖式簡單說明】 圖1係表示自凝結芽胞桿菌AKC-004菌體精製之α·半乳 糖酶之最佳pH值範圍(實施例2)。 圖2係表示自凝結芽胞桿菌AKC-004菌體精製之α-半乳 糖酶之穩定pH值範圍(實施例2)。 圖3係表示自凝結芽胞桿菌AKC-004菌體精製之α-半乳 129208.doc -39- 200846472 糖酶之最佳溫度範圍(實施例2)。 圖4係表示自凝結芽胞桿菌AKC-004菌體精製之α-半乳 糖酶之穩定溫度範圍(實施例2)。 圖5係表示自凝結芽胞桿菌AKC-004菌體精製之α-半乳 糖酶之SDS=PAGE(實施例2)之結果。 圖6係表示對使用自凝結芽胞桿菌AKC-004株精製之α-< 半乳糖酶的糖合成(實施例3)之反應液進行HPLC分析的結 果。 圖7係表示對使用自重組大腸桿菌JM109株獲得之α-半乳 糖酶的糖合成(實施例5)之反應液進行HPLC分析的結果。 圖8係表示對使用培養凝結芽胞桿菌AKC-004株而獲得 之微生物觸媒的糖合成(實施例3)之反應液進行HPLC分析 的結果。Two days after the culture was carried out, a 10 mL amount of the cultured cells was recovered into a test tube of i5 melon capacity. The supernatant was removed by centrifugation at 10,000 rpm on a 15 mL tube in which the culture solution was recovered. Then, add 1 mL of 1 mM • sodium acetate buffer (pH 5.0), resuspend, and then transfer the suspension to a 2 mL polypropylene tube. The tube was centrifuged again, and after removing the supernatant, 300 pL of sugar solution (pH of 5. 〇1 mM vinegar-sodium citrate buffer containing 62.5% sucrose and galactose 12.5%) was added. The vortex is mixed to sufficiently suspend the cells, and the sugar synthesis reaction starts. The reaction temperature of the present sugar synthesis reaction was 6 Torr: and the rotation speed was 12 (10) rpm. After 38 hours from the start of the sugar synthesis reaction, the reaction solution was recovered for 4 Torr, and it was thoroughly mixed with 960 called rectified water. The heat inactivation of the enzyme was carried out at 99 ° C for 1 minute. After the diluted sugar liquid was returned to normal temperature, it was analyzed by a high performance liquid chromatography using a "Hypercarb" (manufactured by Thermoelectron) column, and the result was that the raffinose content in the sugar-producing sugar was 91% ( The concentration of the sweet raffinose in the reaction solution was 0.32% by weight). Example 9 Bacillus coagulans AKC_006 strain (registered number: FERM P-21094; depository: patented bio-registration center of the Institute of Industrial Technology, Independent Administrative Corporation) on Tryptose Blood Agar Base (TBAB) plate medium (Difco), cultured at 55 for 1 day to form colonies. One platinum ear was inoculated to a mixture of 30 mL of the medium shown in Table 1 in a 150 mL gluten-free flask to obtain 55. 〇, 150 rpm conditions for 2 days. 129208.doc •38- 200846472 After 2 days of this culture, 10 mL of the cultured cells were recovered into a 15 mL-capacity test tube. The supernatant was removed by centrifugation at 10,000 rpm on a 15 mL tube in which the culture solution was recovered. Then, 1 mL of 100 mM sodium acetate buffer (pH 5.0) was added, and after resuspending, the suspension was transferred to a 2 mL-capacity polypropylene tube. The tube was centrifuged again, and after removing the supernatant, 300 pL of sugar solution (pH 5, 100 mM sodium acetate buffer containing 62.5% sucrose, galactose 12.5%) was added, and the mixture was made by a vortex mixer. The cells are fully suspended, and the sugar synthesis reaction begins. The reaction temperature of the present sugar synthesis reaction was 60 ° C and the rotation speed was 1200 rpm. After 38 hours from the start of the sugar synthesis reaction, 40 pL of the reaction solution was recovered, and it was thoroughly mixed with 960 pL of distilled water, and heat-deactivated of the enzyme was carried out at 99 ° C for 10 minutes. After the diluted sugar liquid was returned to normal temperature, it was analyzed by a high performance liquid chromatography using a "Hypercarb" (manufactured by Thermoelectron) column, and as a result, the raffinose content in the sugar-producing sugar was 76°/ 〇 (The concentration of raffinose in the reaction liquid is (K86% by weight). [Industrial Applicability] By using the present invention, it is possible to provide a method for selectively producing raffinose by using an inexpensive raw material. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a view showing an optimum pH range of α-galactosidase purified from Bacillus coagulans AKC-004 (Example 2). Fig. 2 shows a self-coagulated Bacillus AKC-004 cell. The stable pH range of refined α-galactosidase (Example 2). Figure 3 shows the optimum temperature of the α-half 129208.doc -39- 200846472 carbohydrate purified from Bacillus coagulans AKC-004 Scope (Example 2) Figure 4 shows the stable temperature range of α-galactosidase purified from Bacillus coagulans AKC-004 (Example 2). Figure 5 shows the self-coagulated Bacillus AKC-004 cells. The result of SDS=PAGE (Example 2) of purified α-galactosidase. The result of HPLC analysis of the reaction mixture of the sugar synthesis (Example 3) of α-< galactosylase purified from Bacillus coagulans AKC-004 strain. Fig. 7 shows the results obtained by using the self-recombinant Escherichia coli JM109 strain. The result of HPLC analysis of the reaction liquid of the sugar synthesis of the α-galactosidase (Example 5). Fig. 8 shows the sugar synthesis of the microbial catalyst obtained by using the cultured Bacillus coagulans AKC-004 strain (Example 3) The reaction solution was subjected to HPLC analysis.

129208.doc •40-129208.doc •40-

Claims (1)

200846472 十、申請專利範圍: 1 · 一種α-半乳糖酶,其具有下述特性: (1)作用··於以蔗糖與半乳糖為原料之脫水縮合反應 中’生成券糖中之棉子糖含有率為〇,5 0/〇以上時,該心半 礼糖酶具有棉子糖合成選擇率為65%以上的性質; U)最佳pH值範圍:3.5〜5〇 ; (3) 穩定PH值範圍:3.5〜10.0; (4) 分子量:約80,000。 2·如請求項1之α-半乳糖酶,其係來自屬於凝結芽胞桿菌 (Bacillus coaguians)之敬竺物。 3·如請求項2之α-半乳糖酶,其中凝結芽胞桿菌係凝結芽胞 桿菌 AKC003株、AKC004株(FERM_ABP10948)(台灣寄存 編號:BCRC 910388)、AKC005株、AKC006株中之任一 者。 4· 一種凝結芽胞桿菌及其變異體,該凝結芽胞桿菌屬於凝 結芽胞桿菌 AKC003 株、AKC004 株(FERM-ABP10948)(台 灣寄存編號:BCRC 910388)、AKC005株、AKC006株中 之任一者。 5 · —種α-半乳糖酶,其包含下述(a)、(b)或(c)中之任一個 胺基酸序列: (a) 序列編號2所表示之胺基酸序列; (b) 序列編號2所表示之胺基酸序列中,一個或數個胺 基酸經缺失、置換及/或附加,且具有α-半乳糖酶活性的 胺基酸序列; 129208.doc 200846472 (c)與序列編號2辦主_ 儿2所表不之胺基酸序列具有6〇%以上之 6· 同源性’且具有《半乳糖酶活性的胺基酸序列。 一種α-半乳糖酶基因,其對包含下述⑷、⑻或⑷中之 任一個胺基酸序列之《-半乳糖酶進行編碼: 、a)汗列編5虎2所表示之胺基酸序列; W序列編號2所表示之胺基酸序財,-個或數個胺 基酸經缺失、置換及/或附加,且 ❿ 胺基酸序列; +礼糖_活性的 (c)與序列編號2所表 因 、之胺基駄序列具有60%以上之 ° 且具有α_半乳糖酶活性的胺基酸序列。 一種半乳糖酶基因,並 ,_ 八包3以下(a)或(b)之鹼基序列: ⑷序列、扁#ul所表示之驗基序列; W序列編t所表示之驗 經缺失、置換中—個或數個鹼基 置換及/或附加,且編碼具、 蛋白質的鹼基序列。 、 礼糖酶活性之 8· 種重組載體,其含有 因。 有如“項6或〜半乳糖酶基 9. -種轉形體’其導入有如請求 或如請求項8之重組載體。 之半乳糖酶基因 10’ -種(X-半乳糖酶’其係培養如請求 U. 一種酶組合物,其含有如請求項15 #形體而獲得。 之α_半乳糖酶。 3、5或1 〇中任一項 12.如請求項U之酶組合物,其進 酶、β-葡萄糖苦酶、卜半乳糖酶葡萄糖苦 纖維素酶、木聚糖 129208.doc 200846472 酶、蛋白酶、半乳聚糖酶、阿拉伯聚糖酶、甘露聚糖 酶、鼠李半乳糖醛酸酶、聚半乳糖醛酸酶、果膠甲酯 酶、果膠解離酶、及聚半乳糖醛酸解離酶中之至少一種 以上之成分。 13, —種棉子糖合成試劑,其含有如請求項或12中任一項 之酶組合物。 14·200846472 X. Patent application scope: 1 · An α-galactosidase which has the following characteristics: (1) Action · In the dehydration condensation reaction of sucrose and galactose as raw materials, the raffinose in the vouchers When the content is 〇, 50 〇 or more, the heart sucrose enzyme has a carnosamine synthesis selectivity of 65% or more; U) optimal pH range: 3.5 to 5 〇; (3) stable PH Value range: 3.5 to 10.0; (4) Molecular weight: about 80,000. 2. The alpha-galactosidase of claim 1 which is derived from a sacred substance belonging to the Bacillus coaguians. 3. The α-galactosidase of claim 2, wherein any one of Bacillus coagulans bacillus AKC003 strain, AKC004 strain (FERM_ABP10948) (Taiwan registration number: BCRC 910388), AKC005 strain, and AKC006 strain. 4. A Bacillus coagulans and a variant thereof, the Bacillus coagulans belonging to any one of Bacillus coagulans AKC003 strain, AKC004 strain (FERM-ABP10948) (Taiwan deposit number: BCRC 910388), AKC005 strain, and AKC006 strain. An alpha-galactosidase comprising the amino acid sequence of any one of the following (a), (b) or (c): (a) an amino acid sequence represented by SEQ ID NO: 2; An amino acid sequence having one or several amino acids deleted, substituted and/or added, and having α-galactosidase activity in the amino acid sequence represented by SEQ ID NO: 2; 129208.doc 200846472 (c) The amino acid sequence having a galactose activity of 6 〇% or more with the amino acid sequence represented by SEQ ID NO: 2 is not more than 6 〇. An α-galactosidase gene encoding a "galactosidase encoding an amino acid sequence of any one of the following (4), (8) or (4): a) an amino acid represented by Khan 2 The sequence; the amino acid sequence represented by W SEQ ID NO: 2, the deletion or substitution and/or addition of one or several amino acids, and the ❿ amino acid sequence; + saccharide _ active (c) and sequence The amino acid sequence of No. 2 has an amino acid sequence of 60% or more and has α-galactosidase activity. A galactosidase gene, and _ eight packets of 3 or less (a) or (b) base sequence: (4) sequence, the sequence of the sequence represented by the flat #ul; W sequence code t to indicate the deletion, replacement A medium or a few base substitutions and/or additions, and encoding a base sequence of a protein or a protein. , a caro-enzyme activity of 8 kinds of recombinant vectors, the content of which. Such as "Item 6 or ~ galactosyl group 9. - morphine" which is introduced with the recombinant vector as requested or as claimed in item 8. The galactosidase gene 10'-species (X-galactosidase' Request U. An enzyme composition comprising α-galactosidase as claimed in claim 15 #. Any of 3, 5 or 1 12 12. The enzyme composition of claim U, the enzyme , β-glucosidase, galactosidase, glucosinolate, xylan 129208.doc 200846472 enzyme, protease, galactanase, arabinase, mannanase, rhamnogalacturonan a component of at least one of an enzyme, a polygalacturonase, a pectin methylesterase, a pectin dissociation enzyme, and a polygalacturonan dissociating enzyme. 13. A raffinose synthesis reagent, which contains the request The enzyme composition of any one of clauses or 12. 一種棉子糖之製造方法,其特徵在於:其係使用如請求 項1至3、5、或1〇中任一項之心半乳糖酶、如請求項1}或 12之酶組合物、或者如請求項13之棉子糖合成試劑。 15. 16. 一種棉子糖之製造方法,其特徵在於:其係利用培養屬 於凝結芽胞桿菌之微生物而獲得之微生物觸媒。 一種棉子糠之製造方法,其特徵在於··其係利用培養屬 於减結芽胞桿菌AKC003株、AKC004株(FERM-ABPl〇948)(台灣寄存編號:BCRC 91〇388)、akc〇〇5 株、AKC006株中之任一者的凝結芽胞桿菌及/或其變異 體而獲得之微生物觸媒。 1 7· —種棉子糖之製造方法,其特徵在於:其係利用培養如 請求項9之轉形體而獲得之微生物觸媒。 18·如请求項14至17中任一項之棉子糖之製造方法,其中生 成养糖中之棉子糖含有率為6 5 %以上。 19·如請求項14至18中任一項之棉子糖之製造方法,其係使 用蔗糖及半乳糖作為原料。 2 0 ·如明求項19之棉子糖之製造方法,其中原料中之蔗糖濃 度為30% (w/v)〜90% (w/v),原料中之半乳糖濃度為2% (w/v)〜45% (w/v) 〇 129208.docA method for producing raffinose, which is characterized in that it uses a heart galactosidase according to any one of claims 1 to 3, 5, or 1 , an enzyme composition as claimed in claim 1} or 12, or The raffinose synthesis reagent of claim 13. 15. A method for producing raffinose, which is characterized in that it is a microbial catalyst obtained by culturing a microorganism belonging to Bacillus coagulans. A method for producing cotton scorpion scorpion, characterized in that it is cultured and belongs to Bacillus anaterium AKC003 strain, AKC004 strain (FERM-ABP1〇948) (Taiwan registration number: BCRC 91〇388), and akc〇〇5 strain A microbial catalyst obtained by Bacillus coagulans and/or a variant thereof of any of the AKC006 strains. A method for producing a raffinose, which is characterized in that it is a microbial catalyst obtained by cultivating the transformant of claim 9. The method for producing raffinose according to any one of claims 14 to 17, wherein the raffinose content in the production of the sugar is 65 % or more. The method for producing raffinose according to any one of claims 14 to 18, which uses sucrose and galactose as raw materials. The manufacturing method of the raffinose according to the item 19, wherein the sucrose concentration in the raw material is 30% (w/v) to 90% (w/v), and the galactose concentration in the raw material is 2% (w) /v)~45% (w/v) 〇129208.doc
TW097105759A 2007-02-19 2008-02-19 Novel a-galactosidase TW200846472A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007037505 2007-02-19
JP2007037504 2007-02-19

Publications (2)

Publication Number Publication Date
TW200846472A true TW200846472A (en) 2008-12-01
TWI363093B TWI363093B (en) 2012-05-01

Family

ID=39710020

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097105759A TW200846472A (en) 2007-02-19 2008-02-19 Novel a-galactosidase

Country Status (4)

Country Link
JP (1) JP5006380B2 (en)
CN (1) CN101657544B (en)
TW (1) TW200846472A (en)
WO (1) WO2008102743A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5255266B2 (en) * 2007-12-20 2013-08-07 旭化成ケミカルズ株式会社 Method for producing novel α-galactooligosaccharide
JP5236967B2 (en) * 2008-03-06 2013-07-17 旭化成ケミカルズ株式会社 Method for producing melibiose using a strain belonging to Bacillus coagulans
CN101974583A (en) * 2010-09-20 2011-02-16 南京农业大学 Method for synthesizing alpha-galacto-oligosaccharide by using alpha-galactosidase
BR112018073875A2 (en) * 2016-05-24 2019-02-26 Novozymes As isolated polypeptide, composition, granule, animal feed additive, liquid formulation, animal feed, methods for releasing galactose from plant-based material, to improve one or more performance parameters of an animal and the nutritional value of an animal feed, for prepare an animal feed and to produce the polypeptide, use, polynucleotide, nucleic acid construct or expression vector, and recombinant host cell.
MX2018013875A (en) * 2016-05-24 2019-09-04 Novozymes As Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity.
AU2017270231A1 (en) 2016-05-24 2018-11-15 Novozymes A/S Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity
CN106282142B (en) * 2016-08-05 2019-05-31 南京林业大学 A kind of preparation method for the alpha-galactosidase that beta-Mannosidase content is low
CN110066780A (en) * 2019-03-29 2019-07-30 上海国龙生物技术集团有限公司 A kind of feeding alpha-galactosidase solid fermenting production technology
CN114181925A (en) * 2020-09-14 2022-03-15 武汉禾元生物科技股份有限公司 Industrial purification and freeze-drying method for recombinant proteinase K

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4021123B2 (en) * 2000-05-15 2007-12-12 日本甜菜製糖株式会社 New production method of raffinose

Also Published As

Publication number Publication date
JPWO2008102743A1 (en) 2010-05-27
CN101657544A (en) 2010-02-24
CN101657544B (en) 2014-01-29
WO2008102743A1 (en) 2008-08-28
JP5006380B2 (en) 2012-08-22
TWI363093B (en) 2012-05-01

Similar Documents

Publication Publication Date Title
TW200846472A (en) Novel a-galactosidase
EP2470668B1 (en) Immobilization of psicose-epimerase and a method of producing d-psicose using the same
JP5042431B2 (en) A new enzyme isolated from BIFIDOBACTERIUM
Rhimi et al. The acid tolerant L-arabinose isomerase from the food grade Lactobacillus sakei 23K is an attractive D-tagatose producer
KR101987586B1 (en) A composition for preparing tagatose and Methods for producing tagatose using The Same
KR20180111667A (en) A composition for preparing tagatose and Methods for producing tagatose using The Same
He et al. Construction of a food grade recombinant Bacillus subtilis based on replicative plasmids with an auxotrophic marker for biotransformation of D-fructose to D-allulose
WO2022148008A1 (en) Bacillus subtilis genetically engineered bacterium for producing tagatose and method for preparing tagatose
AU2001262068A1 (en) A new enzyme isolated from a bifidobacterium
Li et al. Integrated approach to producing high-purity trehalose from maltose by the yeast Yarrowia lipolytica displaying trehalose synthase (TreS) on the cell surface
JP7344195B2 (en) Enzyme capable of producing galactooligosaccharide derived from Paenibacillus pabuli, and method for producing galactooligosaccharide
KR20210093939A (en) Novel ketose 3-epimerase
US20170267989A1 (en) Method of Production of Rare Disaccharides
KR20180111679A (en) A composition for preparing tagatose and Methods for producing tagatose using The Same
KR101627921B1 (en) A aldolase mutant and a d-tagatose production method by using the same
Zhang et al. A novel Lactococcus lactis l-arabinose isomerase for d-tagatose production from lactose
EP1257638A1 (en) Bacterial isolates of the genus klebsiella, and an isomaltulose synthase gene isolated therefrom
JP4259169B2 (en) Novel α-1,2-mannosidase and gene thereof, and method for producing α-mannosyl sugar compound using the enzyme
JP2004500832A (en) Mutants of lactic acid bacteria overproducing extracellular polysaccharides
KR101940785B1 (en) Hexuronate C4-epimerase mutant from Thermotoga petrophila and uses thereof
JP5236967B2 (en) Method for producing melibiose using a strain belonging to Bacillus coagulans
JP4021123B2 (en) New production method of raffinose
JP2021093954A (en) Enzymes and methods for producing galactooligosaccharides
KR101261004B1 (en) Method for production of lactulose from lactose using by cellobiose 2-epimerase
JP4317966B2 (en) Recombinant vector containing α-glucosidase gene, transformant and method for producing α-glucosidase using the same